Эффективность ингаляционных глюкокортикоидов в терапии бронхиальной астмы у детей
Диссертация
Показано, что долгосрочная терапия ингаляционными глюкокортикоидами способна благоприятно повлиять на течение бронхиальной астмы у детей и улучшить ее отдаленные исходы, независимо от предшествовавшей тяжести течения заболевания. Доказано, что защитный эффект стероидов при условии непрерывного их приема в средневысоких дозах развивается у большинства пациентов в среднем через 6 мес. Несмотря… Читать ещё >
Содержание
- Глава I.
- Глава II.
- Глава III.
- Глава IV.
- Глава V.
- Выводы
Список литературы
- Абдусаламов А.Б., Шафер А. М. Эффективность мембраностабилизирующей терапии при бронхиальной астме//Тер. арх. -1997. -№ 3. -С. 32−37.
- Авдеева О.Е., Лебедин Ю. С., Авдеев С. Н. Гликозилированный муцин-антиген 3EGS сывороточный маркер активности и тяжести при интерстициальных заболеваниях легких//Пульмонология. -1998. -№ 2. -С. 22−27.
- Адо В. А, Мокроносова М. А., Перламутров Ю. Н. Аллергия и лейкотриены//Клин. мед. -1995. -Т. 73. -№ 2. -С. 9−12.
- Айсанов З.Р., Стулова О. Ю., Колмакова Е. Н. и др. Оценка эффективности комбинированной терапии фликсотидом и серевентом у больных бронхиальной астмой/ЯТульмонология. -1998. -№ 3. -С. 14−18.
- Алиев А. М. Иоффе Л.Ц., Дашиев В. А. Диагностическая и оперативная торакоскопия, -Алма-Ата: Медицина. 1988. 34 с.
- Балаболкин ИИ. Бронхиальная астма//Аллергические болезни у детей: Руководство для врачей/Под ред. Студеникина М. Я., Балаболкина И. И., М.: Медицина, 1998. -188−213 с.
- Балаболкин И.И. Современные проблемы детской аллергологии/ЯТедиатрия. -1997. -№ 2. -С. 5−8.
- Баранова И.А., Гаджиев К. З., Чучалин А. С. Остеопороз у больных бронхиальной астмой//Пульмонология. -1999. -№ 3. -С. 6−13.
- Бармина Г. В. Морфология первичного хронического бронхита: гистохимическое, электронно-микроскопическое и морфомегрическое исследование слизистой оболочки: Автореф.дис. канд. мед. наук. -М., 1991. 9 с.
- Бейлина В.Б., Шевелев В. И., Андросов В. В. Роль супрессии фагоцитарных лейкоцитов респираторного тракта в патогенезе хронического бронхита//Пульмонология. -1992. -№ 2. -С. 49−52.
- Беклемишев Н. Д Лейкотриены//Иммунология. -1986. -№ 5. -С. 11−17.
- Белоусов Ю.В., Лукьянов С. В., Середа Е. В. и др. Пуриновые и глюкокортикоидные рецепторы у детей с бронхиальной астмой и хроническими бронхолегочными заболеваниями, сопровождающимися бронхообструктивным синдромом//Пульмонология. -1999. -№ 2. -С. 30−35.
- Болошина Н. А. Черняк А.В., Пашкова Т. А. и др. Эффект будесонида на позднюю астматическую реакцию и повышение бронхиальной гиперреактивности после аллергенной провокации//Пульмонология. -1999. -№ 1. -С. 50−53.
- Бронхиальная астма. Глобальная стратегия. Совместный доклад Национального института Сердце, Легкие, Кровь и ВОЗ//Пульмонология. -1996. -Приложение. -С. 1165.
- Бронхиальная астма. Руководство для врачей России (Формулярная система)//Пульмонология. -1999. -Приложение. -С. 5−15.
- Бронхиальная астма/Под ред. Чучалина А. Г. -М: Агар, 1997. -Т. 1. -12 с.
- Вишневский А.А., Яковлев В. М., Тулеев И. Р. и др.//Педиатрия. -2000. -№ 2. -С. 911.
- Вознесенский Н.А., Чучалин А. Г., Антонов Н. С. Окись азота и легкие//Пульмонология. -1998. -№ 2. -С. 6−10.
- Гайдашез Э.А., Новиков В. Н., Верхоланцев Ю. А. Клинико-диагностическое значение комплексного исследования бронхоальвеолярной лаважной жидкости при неспецифических воспалительных заболеваниях легких у детей//Педиатрия. -1992. -№ 1. -С. 64−68.
- Геппе Н. А. Карпушкина А.В., Большакова Т. Д. и др. Эффективность ингаляционных кортикостероидных препаратов при бронхиальной астме у детей//Росс. вестн. перинат. и педиатрии, — 1997. -Т. 42. № 4. -С. 39−43.
- Гиннатуллин Р.У., Жаков Я. И., Федоров И. А. Морфологические аспекты патогенеза атопической бронхиальной астмы тяжелого течения у детей//Педиатрия. -1997. -№ 5. -С. 4−8.
- Глюэр .С.С. (Gluer С.С.) Роль количественной ультразвуковой денситометрии в диагностике остеопороза/Юстеопороз и остеопатиии. -1999. -№ 3. С. 33−39.
- Горелова Ж.Ю., Ладодо К. С., Левачев М. М., Лупинович В. Л. и др. Роль полиненасыщенных жирных кислот в лечебном питании детей с аллергическими заболеваниями//Вопросы питания. -1999. -Том 68. -№ 1. -С. 31−35.
- Горячкина Л. А., Терехова Е. П., Арутюнов Т. Г. и др. Сравнительная эффективность монотерапии сальметеролом, флютиказон пропионатом и их комбинацией при атопической бронхиальной астме//Пульмонология. -1999. -№ 3. -С. 65−70.
- Григоренко А.А., Макаров И. Ю. Корреляционный анализ морфофункционального состояния семенников и бронхов у больных бронхиальной астмой//5 Нац. конгр. по б-ням орг. дых. -М. -1995. -№ 1473.
- Гущин И.С. Аллергическое воспаление и его фармакологический контроль. -М.: Фармарус принт, 1998. -69 с.
- Двойрин В.В., Клименков А. А. Методика контролируемых клинических испытаний. -М.: Медицина, 1985. -23 с.
- Драпкина О.М., Задорожная О. О., Ивашкин В. Т. и др. Особенности синтеза оксида азота у больных инфарктом миокарда//Клин. мед. -2000.-№ 3. -С. 19−23.
- Дрожжев М.Е., Каганов С. Ю. Гормонозависимая бронхиальная астма у детей: клинические особенности и лечение//Росс. вестн. перинат. и педиатриии. -1995. -Т. 40. -№ 6. -С. 31−37.
- Емельянов А.В., Шевелев С. Э., Амосов В. И. и др. Эффективность и безопасность ингаляционных глюкокортикоидов у больных бронхиальной астмой/ЛТульмонология. -1999. -№ 1. -С. 39−42.
- Емельянов А. В. Трофимов В.И. Влияние гдюкокортикоидной терапии на показатели минерального обмена у больных бронхиальной астмой//Клин. мед. -1995. -Т. 73. -№ 2. -С. 23−25.
- Ермаков В.Е., Соколов А. С., Корчагин В. П. и др. Фармакоэкономическая эффективность применения отечественных противоастматических средств/ЛТульмонология. -1997. -№ 3. -С. 65−70.
- Жмуров В. А. Лапик С.В., Попова Т. В. Состояние окислительного метаболизма и антиокситантной защитной системы в альвеолярных макрофагах у больных бронхиальной астмой/ЛТульмонология. -1995. -№ 4. -С. 60−63.
- Идиопатический фиброзирующий альвеолит, Москва, ноябрь 1998 г.: Конференция в НИИ пульмонологии МЗ РФ/ЛТульмонология. -1999. -№ 1. -С. 10−23.
- Кахновский Л. А. Маринин В.Ф., Архипова С. В., Сорокина Л. А. Роль и место альдецина в лечении бронхиальной астмы/ЛТульмонология. -1998. -№ 1. -С. 88−90.
- Кахновский И.М., Маринин В. Ф., Архипова С. В. и др. Комплексная оценка эффективности ингакорта при лечении больных бронхиальной астмой//Тер. арх. -1998. -Т. 70. -№ 9. -С. 73−76.
- Кахновский И.М., Маринин В. Ф., Архипова С. В. и др. Комплексная оценка эффективности альдецина при лечении больных бронхиальной астмой//Тер. арх.1998. -Т. 70. -№ 3. -С. 22−25.
- Климанская Е.В. Бронхоскопия при бронхиальной астме у детей//Дет. доктор.1999. -№ 2. -С. 27−29.
- Климанская Е.В., Кодолова И. М., Сосюра В. Х. Тюрин Н.А. Клинико-морфологические сопоставления при бронхиальной астме и хронической неспецифической пневмонии у детей//Педиатрия. -1974. -№ 7. -С. 12−16.
- Коган А.Х., Даниляк И. Г., Стремоухова А. А. Реакция генерации активных форм кислорода лейкоцитами на гисгамин при различных формах тяжести обострения бронхиальной астмы//Пульмонология. -1995. -№ 1. -С. 30−34.
- Кокосов А.Н., Гольденберг Ю. М. Мищенко В.П. Перекисное окисление липидов и гемостаз на этапах формирования хронического бронхита и бронхиальной астмы//Пульмонология. -1995. -№ 2. -С. 38−43.
- Коровина О. В. Собченко С.А. Международные мед. обзоры. -1993. -№ 2. -С. 120 123.
- Ксензова Л.Д. Биосинтез эйкозаноидов гранулоцитами периферической крови у детей с атопическими заболеваниями: Дис.канд. мед. наук. -М., 1997. 134−135 с.
- Кудрявцева А.В., Балаболкин И. И., Кучеренко А.Г и др. Опыт лечения бронхиальной астмы тяжелого течения у детей с применением ингаляционных глюкокортикостероидов//Педиатрия. -1997. -№ 2. -С. 102−104.
- Куммер Ф. Дифференциальная диагностика бронхиальной астмы и хронических обструктивных заболеваний легких. Современные рекомендации по лечению бронхиальной астмы и хронических обструктивных заболеваний легких//Тер. арх. -1995.-Т. 67. -№ 12. -С. 66−71.
- Лайт Р.У. Болезни плевры, -М.: Медицина. 1986, 73 с.
- Леонова В.Г. Анализ эритроцитарных популяций в онтогенезе человека, -Новосибирск: Наука, 1997. 105−108 с.
- Лещенко И.В., Кузнецова Е. И. Результаты длительного лечения ингакортом больных бронхиальной астмой//Тер. арх. -1997. -Т. 69. -№ 12. -С. 52−54.
- Лизенко М.В., Петровский В. И., Бахирев А. М. Корригирующее влияние гдюкокортикоидов, разгрузочно-физической терапии на липидный статус эритроцитов больных бронхиальной астмой//Пульмонология. -1999. -№ 1. -С. 24−28.
- Лизенко М.В., Петровский В. И., Котенко Т. В. Изменение липидного состава липопротеидов сыворотки крови в процессе лечения гормонами больных бронхиальной астмой//Тер. арх. -1995. -Том 67. -№ 11. -С. 35−38.
- Линдрус X. Применение высоких доз кортикостероидов в виде ингаляций при лечении астмы/УПульмонология. -1991. -№ 2. -С. 38−40.
- Лукомский Г. И., Шулутко М. Л., Виннер М. Г., Смешнев А. С. Бронхология, -М.: Медицина, 1973. -76 с.
- Лукомский Г. И., Шулутко М. Л., Виннер М. Г. и др. Бронхопульмонология, -М.: Медицина, 1982. 64 с.
- Лукьянчиков B.C., Калинин А. П. Остеопороз//Клин. мед. -1997. -Т. 75. -№ 6. -С. 20−23.
- Лупинович В.Л. Оценка влияния соотношения полиненасыщенных жирных кислот омега 6 и омега 3 в рационе на состав липидов тканей крыс: Дис.канд. мед. наук. -М., 1988. -43 с.
- Мазуров В. И. Зоткин Е.Г., Шемеровская Т. Г. и др. Особенности развития стероидного остеопороза у больных ревматоидным артритом и возможности его профилактики активными метаболитами витамина D//Ocreonopo3 и остеопатии. -1998. -№ 3. -С. 28−31.
- Маколкин В.И., Овчаренко С. И., Шеянов М. В. Факторы, определяющие течение и отдаленные исходы бронхиальной астмы: медикаментозная терапия//Клин. мед. -1997. -Т.75. № 7. -С. 59−64.
- Марков Х.М. О биорегуляторной системе L-аргинин-окись азота//Патол. физиол. и эксперим. терапия. -1996 -№ 1. -С. 34−39.
- Марков Х.М. Окись азота в физиологии и патологии почек//Вестн. Росс. Акад. наук. -1996№ 7. -С. 73−78.
- Марков Х. М Окись азота и окись углерода новый класс сигнальных молекул//Успехи физиол. наук. -1996. -Т 27. -№ 4. -С. 30−43
- Марова Е.И. Классификация остеопороза/Юстеопороз и остеопатии. -1998. -№ 1. -С. 8−12.
- Масуев К.А. Эйкозаноиды и бронхиальная астма//Пульмонология. -1993. -№ 1. -С 78−83.
- Маянский Д.Н. Патогенез бронхиальной астмы//Тер. арх. -1995. -Т. 67. -№ 12. -С. 77−80.
- Маянский Д.Н., Макарова О. П., Шишкина Л. Н. и др. Провоспалительная активность бронхоальвеолярной лаважной жидкости при обострении хронических заболеваний легких//Пульмонология. -1998. -№ 4. -С. 44−50.
- Меньшикога Е.Б., Зенков Н. К. Окислительный стресс при воспалении//Успехи совр. биологии. -1997. -Т. 117. -№ 2. -С. 155−171.
- Механизмы воспаления бронхов и легких и противовоспалительная терапия//Под ред. ФедосееваГ.Б., -СПб.: Нордмедиздат, 1998. -688 с.
- Мозапевский АФ., Яковлев А. А. Смирнова Е.А. Содержание соединений группы просганоидов в крови и слюне детей с хроническими неспецифическими заболеваниями легких//Педиатрия. -1997. -№ 5. -С. 14−17.
- Молостова Т.Н. Ингаляционные глюкокортикоиды в лечении больных бронхиальной асмтой//Тер. арх. -1991. -№ 3. -С. 143−147.
- Молостова Т.Н. Эффективность применения пульмикорт-турбухалер в лечении больных бронхиальной астмой//Пульмонология. -1994. -№ 2. -С. 32−8.
- Москалев М.Н., Шклярова Б. С., Неронов А. Ф. Влияние дитека на перекисное окисление липидов при бронхиальной астме//4 Нац. конгресс по бол-ням органов дыхания: Сб. резюме, -М. -1994. -№ 1087.
- Мотус И.Я. О биопсии в пульмонологии//Пульмонология. —1998. -№ 4. —С. 73−78.
- Насонов E. JL, Скрипников И. А., Насонова В. А. Проблема остеопороза в ревматологии. Проблема остеопороза в ревматологии, -М.: Стин, 1997. -18 с.
- Национальная программа «Бронхиальная астма у детей. Стратегия лечения и профилактика"//Москва, 1997.-С 11−21.
- Невзорова В.А., Гельцер Б. И. Окись азота и гемоциркуляция легких//Пульмонология. -1997. -№ 2. -С. 80−85.
- Невзорова В.А., Елисеева Е. В., Зуга М. В. и др. Нитрооксидергические механизмы регуляции бронхов и их значение в патогенезе бронхиальной астмы//Тер. арх. -1998. -Т. 70. -№ 3. -С. 13−18.
- Невзорова В.А., Зуга М. В., Гельцер Б. И. Роль окиси азота в регуляции легочных функций//Тер. арх. -1997. -№ 3. -С. 68−73.
- Невзорова В.А., Протопопова М. Ю., Елисеева Е. В. и др. НАДФ Н-диафоразная активность эпителия дыхательных путей при бронхиальной астме/ТПульмонология.1997. -№ 2. -С. 68−71
- Непомнящих Г. И., Непомнящих JI.M. Морфогенез и прижизненная патоморфологическая диагностика хронических патологических процессов в легких//Пульмонология. -1997. -№ 2. -С. 7−16.
- Овчаренко С.И., Елисеев О. М. Астма и хронические обструктивные заболевания легких. Проблемы диагностики и лечения//Тер. арх. -1997. № 8. -С. 64−65.
- Овчаренко С.И., Шеянов М. В., Маколкин В. И. Факторы риска и пути предотвращения ранних неблагоприятных исходов бронхиальной астмы//Тер. арх.1998. -Т. 70. -№ 3. -С. 18−22.
- Овчаренко С.И., Шеянов М. В., Маколкин В. И. Факторы, определяющие отдаленные исходы бронхиальной астмы: роль качества медицинской помощи и обучения пациентов//Тер. арх. -1996. -Т. 68. -№ 3. -С. 41−44.
- Оганов B.C. Гипокинезия фактор риска остеопороза/Юстеопороз и остеопатии. -1998. -№ 1.-С. 13−17.С
- Папаян А.В., Бенаменьо Ж. П., Сомов Е. Е. и др. Стероидная катаракта при нефротическом синдроме у детей//Педиатрия. -1993. -№ 3. -С. 94−97.
- Петров В.И., Смоленое И. В., Аликова О. А. и др. Дозозависимые эффекты флютиказона пропионата у детей с тяжелым течением бронхиальной астмы//Пульмонология. -1999. -№ 3. -С. 75−82.
- Петров В.И., Смоленов И. В., Медведева С. С. и др. Качество жизни детей с бронхиальной астмой: влияние базисной противовоспалительной терапии//Аллергология. -1999. -№ 4. -С. 4−10.
- Петров В.И., Смоленов И. В., Смирнов Н. А. Безопасность и побочные эффекты ингаляционных кортикостероидов у детей с бронхиальной астмой//Пульмонология. -1998. -№ 3. -С. 88−95.
- Польнер С.А. Влияние глюкокортикоидных препаратов бекотида и бекодиска на реактивность бронхов у больных бронхиальной астмой//Клин. мед. -1997. -Т. 75. -№б. -С. 44−46.
- Порядин Г. В., Самсонов, А Н., Балаболкин И. И. и др Новый подход к оценке гиперреактивности бронхов у детей, больных бронхиальной астмой//Педиатрия. -1994. -№ 6. -С. 5−7.
- Прасолова Н.И. Стероидная зависимость у больных бронхиальной астмой (возможные причины и пути ее устранения): Дис. канд. мед. наук. М., 1991. -34 с.
- Прахин Е.И., Прохоренков В. И., Терещенко С. Ю. Роль структурно-функционального состояния мембран в патогенезе различных нозологических форм атопических заболеваний у детей//Педиатрия. -1997. -№ 2. -С. 14−19.
- Прахин Е.И., Терещенко С. Ю. Липиды плазматических мембран и липидные медиаторы воспаления у детей с атопическими заболеваниями роль в патогенезе и возможные пути коррекции//Педиатрия. -2000. -№ 2. -С. 82−88.
- Реброва Р.Н. Грибы рода Candida при заболеваниях негрибковой этиологии, -М.: Медицина, 1989. -11−16 с.
- Резник И.Б., Щербина А. Ю., Кулак Ю. В. и др. Особенности воспаления дыхательных путей при бронхиальной астме у детей//Педиатрия. -1997. -№ 2. -С. 9−14.
- Ремизов О.В. Поражение опорно-двигательной системы у детей, больных сахарным диабетом: Автореф. дис. канд. мед. наук. -М., 1998. -9−18 с.-ч I45#v>-Г V 'г
- Ремизов О.В., Мач Э.С., Пушкова О. В. и др. Состояние костно суставной системы при сахарном диабете у детей//Остеопороз и остеопатии. -1999. -№ 3. -С. 1822.
- Рожинская Л.Я., Марова Е. И. Эндокринологические аспекты остеопороза//3-й Всероссийский съезд эндокринологов: тезисы докладов. -М, 1996. -С. 199−200.
- Романова Л.К., Овчаренко С. И., Младковская Т. Б. и др. Особенности клеточных реакций в легких во время обострения бронхиальной астмы//Пульмонология. -1992. -№ 1. -С. 20−27.
- Святкина О.Б., Тулуевская Л. М., Погомий Н. Н. и др.//Педиатрия. -1983. -№ 12. -С. 15−18.
- Северина И.С. Растворимые формы гуанилатциклаз, механизм активации оксидом азота, роль в агрегации тромбоцг~ов//Вестн. Росс. Акад. мед. наук. -1995. -№ 2. -С. 41−46.
- Степанян И.Э. Вопросы ингаляционной кортикостероидной терапии больных бронхиальной астмой//Тер. арх. -1997. -Т. 69. -№ 8. -С. 60−62.
- Страчунский Л.С., Суина З. М. Применение бекотида в высоких дозах при бронхиальной астме//Клин. фарм. и терапия. -1993. -№ 1. -С. 37−38.
- Суточникова О, А, Чеоняк А. В., Дмитров Е. В., Чучалин А. Г. Противовоспалительная активность отечественного ингаляционного кортикостероида будесонида//Пульмонология. -1995. -№ 3, — С. 46−48.
- Суточникова О.А., Самсонова М. В., Черняк А. В., Черняев А. Л. Ингаляционная глюкокортикостероидная терапия больных бронхиальной астмой легкого течения. Влияние на воспаление и гиперреактивность//Пульмонология. -1996. -№ 4. -С. 21−27.
- Суточникова О. А, Черняев А. Л., Чучалин АГ. Ингаляционные глюкокортикостероиды при лечении бронхиальной астмы//Тер. арх. -1995. -№ 11. -С. 78−83.
- Татарский А. Р. Алиева К.М. Тромбоциты, физиологическая активность. Роль в патогенезе бронхиальной атсмы//Пульмонология. -1991. -№ 2. -С. 48−54.
- Терещенко С.Ю. Клинико-прогностическая оценка структурно-функционального состояния мембран эритроцитов у детей, страдающих атопическими заболеваниями: Дис.канд. мед. наук. -Красноярск, 1996. -102 с.
- Терещенко Ю.А., Тисленко JI.H., Ванетик Е. И. Ингаляционный глюкокортикостероид ингакорт при лечении бронхиальной астмы: эффективность длительной терапии/Яер. арх. -1998. -Т. 70. -№ 3. -С. 26−29.
- Трофимова В.И. Особенности формирования бронхообструкгивного синдрома у больных бронхиальной астмой при нарушении гормонального гомеостаза: Дне. д-ра. мед. наук. -СПб., 1990. -78 с.
- Тугуд Дж. X. (Toogood J.H.) Побочные эффекты лечения ингалируемыми стероидами больных астмой/Яер. арх. -1995. -№ 10. -С. 76−80.
- Федоров И.А. Характеристика воспалительного процесса в бронхиальном дереве у детей при тяжелых формах бронхиальной астмы в фазу ремиссии//Пульмонология. -1999. -№ 1. -С. 63−67.
- Федосеев Г. Б. Яковлева Н.В., Вишнякова А. В. и др. Механизмы воспаления бронхов и легких и противовоспалительная терапия, -СПб: Нордмед-Издат, 1998. -26 с.
- Цой А. Н. Параметры фармакокинетики современных ингаляционных глюкокортикостероидов//Пульмонология. -1999. -№ 2. -С. 73−79.
- Цой А.Н., Гафуров М. С. Эффективность и безопасность применения препарата пульмикорт турбухалер 1000 мкг/сутки у больных с обострением бронхиальной астмы, ранее не получавших ингаляционных глюкокортикостероидов//Пульмонология. -1999. -№ 1. -С. 71−76.
- Цой А.Н., Шор О. А. Динамика ОФВ1 в период длительного лечения антиастматическими препаратами и после их отмены/ЯТульмонология. -1995. -№ 4. -С. 42−46.
- Цой А.Н., Шор О. А., Гафуров М. С. Эффективность ингаляционных глюкокортикостероидов при различном режиме дозирования и в комбинации с препаратами теофиллина у больных бронхиальной астмой/Яер. арх. -1997. -Т. 69. -№ 3. -С. 27−30.
- Черняев A.JI. Некоторые вопросы патогенеза и патологической анатомии бронхиальной астмы//Архив патологии. -1998. -№ 2. -С. 63−69.
- Черняк А.В. Влияние fc агонисгов на бронхиальную гиперреактивность у больных бронхиальной астмой: Дне.канд. мед. наук. -М., 1996. -78 с.
- Черняк А.В. Влияние отечественных 02 агонистов на гиперреактивность дыхательных путей//Пульмонология. -1996. -№ 4. -С. 46−51.
- Чучалин А.Г. Бронхиальная астма, -М: Медицина, 1998. Т.1. -158 с.
- Чучалин А.Г., Калманова Е. Н., Айсанов З. Р. и др. Применение фиксированных комбинаций ингаляционных кортикостероидов и длительно действующих 02 агонистов в лечении бронхиальной астмы//Пульмонология. -2000. -№ 6. -С. 81−85.
- Чучалин А.Г., Молостова Т. Н. Оценка эффективности будесонида у больных бронхиальной астмой двойным слепым перекрестным плацебо-контролируемым методом//Клин. фарм. и терапия. -1993. -№ 1. -С. 23−26
- Чучалин А.Г., Черняк Б.А, Медникова О. Б. и др. Эффективность сочетанного применения флутиказона пропионата и сальметерола при 18-месячной терапии больных стероидзависимой бронхиальной астмой//Пульмонология. -1998. -№ 3. -С. 64−70.
- Шеянов М.В., Овчаренко С. И., Маколкин В. И. Влияние кортикостероидной терапии на отдаленные исходы бронхиальной астмы//Пульмонология. -1995. -№ 4. -С 64−67.
- Шмушкович Б.И. Кортикозависимая бронхиальная астма (Вопросы клиники, осложнений, патогенеза и лечения): Дис. д-ра мед наук. -Москва, 1995. -68 с.
- Яценко В.П., Брюзгина Т. С., Хоменко В. Е. и др.//Клин. лаб. диагностика. -1997. -№ 4. -С. 16−17.
- Abrukteish F., Kirkpatrick J.N.P., Russell G. Posterior subcapsular cataract and inhaled corticosteroid therapy//Thorax. -1995. -Vol. 50. -P. 674−676.
- Adcock I.M., Brown C.R., Kwon O.J. et al. Oxidative stress induces NF-kB DNA binding and inducible NOS mRNA in human epithelial cells// Biochem. Biophys. Res. Commun. -1994. -Vol. 199. -P. 1518−1524.
- Adkins K.K., Levan T.D., Miesfeld R.L. et al. Glucocorticoid regulation of GM -CSF: evidence for transcriptional mechanisms in airway epithelial cells//Am. J. Physiol. -1998 Aug. -Vol. 275. -№ 2 (Ptl). -P. 372−378.
- Agertoft L., Pedersen S. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler//J. Allergy. Clin. Immunol. 1997 Jun. -Vol. 99. -№ 6 (Ptl). -P. 773−780.
- Agertoft L., Pedersen S. Bone growth and collagen markers in children treated with fluticasone propionate and budesonide//Eur. Respir. J. -1996. -Vol. 9. -Suppl. 23. -P. 295.
- Agertoft L., Pedersen S. Effects of long-term treatment with an inhaled corticosteroids on growth and pulmonary function in asthmatic children//J.Respir. Med. -1994.-Vol. 88.-P. 373−381
- Agertoft L., Pedersen S. Importance of the inhalation device on the effect of budesonide//Arch. Dis. Child. -1993. -Vol. 69. -P. 130−133.
- Ali Baki, Giilay Karaguzel. Short-term effects of budesonide, nedocromil sodium & salmeterol on bronchial hyperresponsiveness in childhood asthma//Acta Paediatrica. Japonica. -1998. -Vol. 40. -P. 247−251.
- Allen D.B. Growth suppression by glucocorticoid therapy/ZEndocrinol. Metab. Clin. North. Am. -1996 Sep. -Vol 25. -№ 3. -P. 699−717.
- Allen D.B. Limitation of short-term studies in predicting long-term adverse effects of inhaled corticosteroids//Allergy. -1999. -Vol. 54. -Suppl. 49. -P. 29−34
- Allen D.B., Mullen M.L., Mullen B. A A meta-analysis of the effect of oral and inhaled corticosteroids on growth//! Allergy. Clin. Immunol. -1994. -Vol. 93. -№ 6. -P. 967 976
- Allen M.B., Ray S.G., Leitch A.G. et al. Steroid aerosols and cataract formation// Brit. Med. J. -1989. -Vol. 299. -P. 432−433.
- Andersson N, Klint S., Randwall G., Wiren J.E. Equipotency of BUD and fluticasone propionate in the vasoconstriction assay//Am. J. Respir. Crit. Care. Med. -1994 -Vol. 49. (Suppl.). -№ 4 (Pt2). -P. 467.
- Andersson P., Ryrfeldt A. Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17alpha, 21-dipropionate in human liver and lung homogenate//J. Pharm. Pharmacol. -1984. -Vol. 36. -P. 763−765.
- Andresen M., Diaz O., Troncoso S. Nitric oxide and respiratory diseases//Rev. Med. Chil. -1997 Aug. -Vol. 125. -№ 8. -P. 935−938.
- Arnon S., Grigg J., Silverman M. Effectiveness of budesonide aerosol in ventilator-dependent preterm babies: a preliminary report/ZPediatr. Pulmonol. -1996 Apr. -Vol. 21. -№ 4. -P. 231−235.
- Aubert J.D., Quadri F., Soler M. Insufficient control of asthma: increase the dose of inhaled steroids or add long-acting beta 2-agonists?//Schweiz. Med. Wochenschr. -1997 Feb. -Vol. 127. -№ 5. -P. 176−181.
- Augusti M.B., Clara P.C. Dysphoria induced by corticoid inhalation. Truth or myth?//Arch. Bronchoneumol. -1995. -Vol. 31. -№ 8. -P. 415−417.
- Backman K.S., Greenberger P.A., Patterson R. Airways obstruction in patients with long-term asthma consistent with 'irreversible asthma'//Chest. -1997 Nov. -Vol. 112. -№ 5. -P. 1234−1240.
- Bancalari L., Dente F.L., Carletti A. et al. Effect of salmeterol on eosinophilic count in induced sputum after late airway response to allergen inhalation in asthmatic subjects//Allergy and Asthma. -1996. -Vol. 16. -№ 5. -P 42.
- Baraldi E., Azzolin N.M., Zanconato S. et al. Corticosteroids decrease exhaled nitric oxide in children with acute asthma//! Pediatr. -1997. -Vol. 131. -№ 3. -P. 381−385.
- Baran D., Faulkner K., Genant H Et al Diagnostic & treatment of osteoporosis//Calcified. Tissue. Int. -1997. -Vol. 3. -№ 151. -P. 433−440.
- Baraniuk J., Murray J.J., Nathan R.A. et al. Fluticasone alone or in combination with salmeterol vs triamcinolone in astma//Chest. -1999 Sep. -Vol. 116. -№ 3. -P. 625−632.
- Barenholtz H. Effect of inhaled corticosteroids on the risk of cataract formation in patients with steroid-dependent asthma//Ann. Pharmacother. -1996. -Vol. 30. -P. 13 241 327.
- Barnes N.C. A comparison of fluticasone propionate, 1 mg daily with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma//Eur. Respir. J. -1993.-Vol. 6.-P. 877−884.
- Barnes N.C. Safety of high-dose inhaled corticosteroids/ZRespir. Med. -1993. -Vol. 87. -Suppl. A. -P.27−31.
- Barnes N.C., Thwaites R.M., Price M.J. The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children//Respir. Med. -1999 jun. -Vol. 93. -№ 6. -P. 402−407.
- Barnes P. Biomarkers for inflammation. Biomarkers in COPD//Sixth Ann. Congress Europ. Respir. Soc. -Abstracts. -1996. -P. 11−13.
- Barnes PJ. Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma// J. Allergy. Clin. Immunol. -1998 Apr. -Vol. 101. -№ 4 (Pt2). -P. 427−433.
- Barnes P.J. Current therapies for asthma. Promise and limitations//Chest. -1997 Feb. -Vol. 111. -Suppl. 2. -P. 17−26.
- Barnes P.J. Effect of corticosteroids on airway hyperresponsiveness//Am. J. Respir. Dis. -1990. -Vol. 141. -P. 70−76.
- Barnes P.J. Efficacy of inhaled corticosteroids in asthma//J. Allergy Clin. Immunol. -1998 Oct. -Vol. 102 (4 Pt 1). -P. 531−8.
- Barnes P.J. Mode of action of steroids in asthma//Corticosteroid therapy in asthma & rhinitis//Ann. Int. Symp., Australia. -1991. -P. 7−10.
- Barnes P.J. New concepts in the pathogenesis of brorchial hyperresponsiveness & astma//J. Allergy. -1989. -Vol. 83. -№ 6. -P. 1013−1026.
- Barnes P.J. Nitric oxide and airway disease//Ann. Med.-1995 Jun.-Vol. 27. -№ 3. -P. 389−393.
- Barnes P.J. NO or no NO in asthma//Thorax. -1996. -Vol. 51. -P. 218−22.
- Barnes P.J., Adcock I.M. Anti-inflammatory actions of steroids: molecular mechanisns//Trends. Pharmacol. Sci. -1993. -№ 14. -P. 436−441.
- Barnes P.J., Liew F.Y. Nitric oxide and asthmatic inflammation//Immunol. Today. -1995. -Vol. 16. -P. 128−130.
- Barnett P.L., Caputo G.L., Baskin M. et al. Intravenous versus oral corticosteroids in the management of acute asthma in children//Ann. Emerg. Med. -1997 Feb. -Vol. 29. -№ 2. -P. 21.2−217.
- Bateman E.D., Britton M., Carrillo J. et al. Salmeterol/fluticasone combination inhaler: a new, effective and well tolerated treatment for asthma//Clin. Drug. Invest. -1998. -Vol. 16. -P. 193−201.
- Beck J., Griese M., Latzin P. et al. Characteristics of flow dependency of nitric oxide in exhaled air in children with cystic fibrosis and asthma//Eur. J. Med. Res. -1999 Aug. -Vol. 4. -№ 8. -P. 335−340.
- Belvisi M.G., Stretton C.D., Barnes P.J. et al. Nitric oxide is the endogenous neurotransmitter of bronchodilatator nerves in human airways//Eur. J. Pharmacol. -1992. -Vol. 210. -P. 221−222.
- Bergmann K.C. Controlled clinical comparative evaluation of fluticasone powder inhalation versus flunisolide dose aerosol in patients with mild to moderate asthma//Pneumologie. -1997 Jan. -51. -№ 1. -P. 27−32.
- Bettendorf М., Albers N. Bauer J. et al. Longitudinal evaluation of salivary Cortisol levels in full-term and preterm neonates//Horm. Res. -1998. -Vol. 50. -№ 6. -P 303 308.
- Binz K., Schmid C., Bouillon R. et al. Interactions of insulin-like growth factor I with dexamethasone on trabecular bone density & mineral metabolism in rats//Eur. J. Endocrinol. -1994. -Vol. 130. -P. 387−393.
- Bisgaard H. Systemic activity of inhaled topical steroid in toddlers studied by knemometry//Acta Paediatr. Int. J. Paediatr. -1993. -Vol. 82. -№ 2. -P. 1066−1071.
- Bisgaard H., Nielsen M.D., Andersen B. et al. Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide//J. Allergy Clin. Immunol. -2988. -Vol. 81. -P. 1088−1095.
- Bjornsson E., Janson C., Hakansson L. et al. Serum eosinophil peroxidase in allergic & non-allergic asthma//Europ. Respir. J. -1993. -Vol. 6. -S. 17. -P. 1106.
- Boer J., Duyvendak M, Schuurman F.E. et al. Role of L-arginine in the deficiency of nitric oxide and airway hyperreactivity after the allergen-induced early asthmatic reaction in guinea-pigs//Br. J. Pharvacol. -1999 Nov. -Vol. 128. -№ 5. -P. 11 141 120.
- Boer J., Meurs H., Coers W. et al. Deficiency of nitric oxide in allergen-induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study//Br. J. Pharmacol. -1996 Nov. -Vol. 119. -№ 6. -P. 1109−1116.
- Boer J., Pouw F.M., Zaagsma J. et al. Effects of endogenous superoxide anion and nitric oxide on cholinergic constriction of normal and hyperreactive guinea pig airway//Am. J. Respir. Crit Care. Med. -1998 Dec. -Vol. 158. -№ 6. -P. 1784−1789.
- Bojic M., Rascovic S., Peric-Popadic A. et al. Leukotrienes in allergic inglammatory reactions//Srp. Arh. Celok Lek. -1998 Sep-Oct. -Vol. 126. -№ 9−10. -P. 382 387.
- Boner A.L., Piacentini G.L. Inhaled corticosteroids in children: Is there a «safe» dosage?//Drug Saf. -1993. -Vol. 9. -№ 1. -P. 9−20.
- Booms P., Cheung D., Timmers M. C et al. Protective effects of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma//J. Allergy. Clin. Immunol. -1997 Mar. -Vol. 99. -№ 3. -P. 330−7.
- Booth H., Richmond I., Ward C. et al. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma//Am. J. Respir. Crit. Care Med. -1995 Jul -Vol. 152. -№ 1. -P. 45−52.
- Bootsma G.P., Koenderman L., Dekhuijzen P.N. et al. Effects of fluticasone propionate and beclomethasone dipropionate on parameters of inflammation in peripheral blood of patients with asthma//Allergy. -1998 Jul. -Vol. 53. -№ 7. p. 653−661.
- Bomefalk E., Dahlen I., Michaelsson K. et al. Age-dependent effect of oral glucocorticoids on markers of bone resorption in patients with acute asthma//Calcif Tissue Int. -1998 Jul. -Vol. 63. -№ 1. -P. 9−13.
- Boulet LP., Laviolette M., Turcotte H. et al. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine//Chest. -1997 Jul. -Vol. 112. -№ 1. -P. 45−52.
- Bousquet J., Chanes P., Lacoste J. et al. Eosinophilic inflammation in asthma//N. Engl. J. Med. -1990. -Vol. 323. -P. 1033−1040
- Bowton D.L., Seeds M.C., Fasano M.B. et al. Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics//Am. J. Respir. Crit. Care Med. -1997 Feb. -Vol 155. -№ 2. -P. 421−425
- Brand P.L., Hoekstra M.O. Diagnosis and treatment of recurrent coughing and wheezing in children younger than 4 years old//Ned-Tijdschr-Geneeskd. -1997 Mar. -Vol. 141. -№ 10. -P. 464−467.
- Brandli D.W., Golde G., Greenwald M. et al. Glucocorticoid-induced osteoporosis: a cross-sectional study//Steroids. -1991. -Vol. 56. -№ 10. -P. 518−23.
- Brattsand R. Development of glucocorticoids with lung selectivity. In: Hargreave F.E., Hogg J.C., Malo J-L., Toogood J.H. (eds). Glucocorticoids and mechanisms of asthma. Amsterdam: Excerpta Medica, 1989. -17−38 p.
- Brattsand R., Axelsson B.I. New inhaled glucocorticosteroids. In: Barnes P.J. (ed). New drugs for asthma. Volume 2, Chapter 13. London, 1992. -193−208 p.
- Brattsand R., Selroos O. Current drugs for respiratory diseases: glucocorticosteroids. In: page C.P., Metzger W.I. (eds). Drugs and the lung. New York: Raven Press Ltd, 1994. -101−220 p.
- Brattsand R., Thalen A., Roempke K. et al. Development of new glucocorticosteroids with a very high ratio between topical and systemic activities//Eur. J. Respir. Dis. -1982. -Vol. 63. -Suppl. 122. -P. 62−73.
- Brewster C.E.//Am. J. Resp. Cell Molecular Biol. -1990. -Vol. 3. -P. 507−511.
- Brunette M. G., Lands L., Thibodeau L.P. Childhood asthma: Prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection//Paediatrics. -1998. -Vol. 81. -P. 624−629
- Burke C., Power C.R., Norris A. et al. Lung function immunopathological changes after inhaled corticosteroid therapy in asthma//Eur. Respir. J. -1992. -Vol. 5. -P. 73−79.
- Burke C.M., Sreenan S., Pathmakanthan S. et al. Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: a controlled study//Thorax. -1996 oct. -Vol. 51. -№ 10. -P. 993−999.
- Busse W.W. Inflammation in asthma: the cornerstone of the disease and target of therapy//! Allergy Clin. Immunol. -1998 Oct. -Vol. 102. -№ 4 (Pt2). -P. 17−22.
- Busse W.W. Leukotrienes and inflammation//Am. J. Respir. Crit. Care Med. -1998 Jun. -Vol. 157. -№ 6 (Pt2). -P. 210−213.
- Butler G.B., Adler K.B., Evans J.N. et al. Modulation of rabbit airway smooth muscle responsiveness by respiratory epithelium//Am. Rev. Respir. Dis. -1987. -Vol. 135. -P. 1099−1104.
- Carter P.M., Heinly T.L., Yates S.W. et al. Asthma: the irreversible airways disease//! Investig. Allergol. Clin. Immunol. -1997 Nov-Dec. -Vol. 7. -№ 6. -P. 566−571.
- Catena E., Mazzarella G., Peluso G. et al. Phenotypic features & secretory pattern of alveolar macrophages in atopic asthmatic patients/ZMonaldi Arch. Chest Dis. -1993. -Vol. 48. -P. 6−15.
- Chaplin M.D., Rooks I.I., Swenson E.W. et al. Flunisolide metabolism and dynamics of a metabolite//Clin. Pharmacol. Ther. -1980. -Vol. 27. -P. 402.
- Chapman K.R., Ringdal N., Backer V. et al. Salmeterol and fluticasone propionate (50/250mcg) administrated via combination Discus inhaler: as effective as when given via separate Discus inhaler//Can. Respir. J. -1999. -Vol. 6. -№ 1. -P. 45−51.
- Chavis C., Chanez P., Vachier I. et al. 5−15diHETE and lipoxins generated by neutrophils from endogenous arachidonic acid as asthma biomarkers/ZBiochem. Biophys. Res. Commun. -1995 Feb. -Vol. 207. -№ 1. -P. 273−279.
- Chavis C., Vachier I., Bousquet J. et al. Generation of eicosanoids from 15 (S)-hydroxyeicosatetraenoic acid in blood monocytes from steroid-dependent asthmatic patients//Biochem-Pharmacol. -1998 Aug. -Vol. 56. -№ 4. -P. 535−41.
- Chetta A., Foresi A., Del-Donno M. et al. Airways remodeling is a distinctive feature of asthma and is related to severity of disease//Chest. -1997 Apr. -Vol. 111. -№ 4. -P. 852−857.
- Chung K.F., Becker A.B., Lazarus S.C. et al. Antigen-induced airway hyperresponsiveness and pulmonary inflammation in allergic dogs//J. Appl. Physiol. -1985. -Vol. 58. -P. 1347−1353.
- Churh M.K., Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cell by antiallergic drugs and salbutamol//Br. J. Pharmacol. -1987. -Vol. 90. -P. 421−429.
- Chylack L.T. Cataracts and inhaled corticosteroids//N. Engl. J. Med. -1998. -Vol. 337. -№ 1. -P. 46−48.
- Clark D.J., Lipworth B.J. Dose-response of inhaled drugs in asthma. An update//Clin. Pharmacokinet. -1997 Jan. -Vol. 32. -№ 1. -P. 58−74.
- Coceani F., Olley P.M. Eicosanoids in the fetal and transitional pulmonary circulation//Chest. -1988. -Vol. 93. -P. 112−117.
- Cockroft D.W., Ruffin R.E., Dolovich J. et al. Allergen-induced in nonallergic bronchial reactivity//Clin. Allergy. -1977. -Vol. 7. -P. 503−513.
- Connett G., Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide//Arch. Dis. Child. -1993. -Vol. 68. -P. 85−87.
- Corrigan C., Kay A. The roles of inflammatory cells in the pathogenesis of asthma & of COPD//Am Rev Respir Dis. -1991. -Vol. 143. -Suppl. -P. 1165−1168.
- Corryn B. Pathology of interstitial lung disease//Am. J. Respir. Crit. Care Med. -1994. -Vol. 15. -№ 61. -P. 76.
- Crimi E., Spanevello A., Neri M. et al. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma//Am. J. Respir. Crit. Care Med. -1998 Jan. -Vol. 157. -№ 1. -P. 4−9.
- Crowley S., HindmarshP.C., Holownia P. et al. The use of low doses of ACTH in the investigation of adrenal function in man//J. Endocrinol. -1991. -Vol. 130. -P. 425−429.
- Cumming R.G., Mitchell P., Leeder S.R. Use of inhaled corticosteroids and risk of cataracts//N. Engl. J. Med. -1998. -Vol. 337. -№ 1. -P. 8−14.
- Dahl R. Are beta2-adrenergic agonists «antiinflammatory»?//Europ. Res. J. -1991. -Vol. 4, Suppl. 14. -P. 89−93.
- Dahl R. Efficacy of fluticasone propionate in adult asthma/ZEurop. Res. J. -1992. -Vol.15. -№ 5. -P. 1085−1089.
- Dahl R., Johansson S.F. Clinical effect of b.i.d. and q.i.d. administration of inhaled budesonide. A double-blind controlled study//Eur. J. Respir. Dis. -1995. -Vol. 67. -P.254−260.
- Dahl R., Ullman A. Efficacy of inhaled corticosteroids//Asthma Management. Topics for the 90s. A Symposium Report Clinical Vision Ltd. 2-nd Ed. -Helsinki, 1994. -P. 18−23.
- Dahlem S.E., Hedquist P., Hammarstrom S. Contractile activities of several cystein-containing leukotrienes in the guinea-pig lung strip//Eur. J. Pharmacol. -1982. -Vol. 86.-P. 207−215.
- Das U.N. Possible role of prostaglandins of pulmonary hypertensions/ZProstaglandins. -1980. -Vol. 4. -P. 163−170.
- Daugberg P. A comparison between nebulised terbutaline, nebulized corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 month of age//Acta Paediatr. -1993. -Vol. 82. -P. 547−551.
- Davies D.E., Polosa R., Puddicombe S.M. et al. the epidermal growth factor receptor and its ligand family: their potential role in repair and remodelling in asthma//Allergy. -1999 Aug. -Vol. 54. -№ 8. P. 771−83.
- De Monchy J.G.R., Kauffman H.F., Venge P. et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reaction//Am. Rev. Respir Dis. -1985. -Vol. 131. -P. 373−376.
- De-Benedictis F.M., Martinati L.C., Solinas L.F. et al. Nebulized flunisolide in infants and young children with asthma: a pilot study//Pediatr. Pulmonol. -1996 May. -Vol. 21.-№ 5.-P. 310−315.
- De-Gouw H.W., Verbruggen M.B., Twiss I.M. et al. Effect of oral L-arginine on airway hyperresponsiveness to histamine in asthma//Thorax. -1999 Nov. -Vol. 54. -№ 11. -P. 1033−1035.
- Delany A.M., Dong Y., Canalis E. Mechanisms of glucocorticoid action in bone cells//! Cell Biochem. -1994. -Vol. 56. -№ 3. -P. 295−302.
- Demoly P., Jafluel D., Chung K.F. et al. Pharmacological specificities and modalities of prescription for corticoids for asthmatic adults/ZPresse Med. -1996 Dec. -Vol. 25. -№ 40. -P. 2025−2030.
- Dequeker J., Maenaut K., Verwilghen J. et al. Osteoporosis in rheumatoid arthritis//Brit. J. Rheumatol. -1997. -Vol. 36. -№ 4. -P. 444−448.
- Dinakar C., Malur A., Raychaudhuri B. et al. Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide//Ann. Allergy Asthma Immunol. -1999 Feb. -Vol. 82. -№ 2. -P. 217−222.
- Djukanovic R., Homeyard S., Gratziou S. et al. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation//Am. J. Respir. Crit. Care Med. -1997 Mar. -Vol. 155. -№ 3. -P. 826−832.
- Dooper M.W., Timmermans A., Aalbers R. et al. Production of diacylglycerol and arachidonic acid in peripheral blood mononuclear cells from patients with asthma and healthy controls//Ann. Allergy Asthma Immunol. -1995 Mar. -Vol. 74. -№ 3. -P. 249−254.
- Doull I.J.M., Freezer N. J., Holgate S.T. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate//Am. J. Respir. Crit. Care Med. -1995. -Vol. 151. -№ 6. -P. 1715−1719.
- Downey G.P., Worthen G.S., Henson P.M. et al. Neutrophil sequestration & migration in localized pulmonary inflammation//Am. Rev. Respir. Dis. -1993. -Vol. 147. -P. 168−176.
- Drazen J.M. Leukotrienes as mediators of airway obstruction//Am. J. Respir. Crit. Care Med. -1998 Nov. -Vol. 158. -№ 5 (Pt 3). -P. 193−200.
- Du J., Cui D., Tian D. The role of nitric oxide in the pathogenesis of asthma//Chung Hua Chieh Ho Ho Hu Hsi Tsa Chih. -1997 Jun. -Vol. 20. -№ 3. -P. 153−156.
- Dunill M.S. The pathology of asthma with special reference to changes in the bronchial mucosa//! Clin. Pathol. -1960. -Vol. 13. -P. 27−33.
- Dupont L.J., Rochette F., Demedts M.G. et al. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma//Am. J. Respir. Crit. Care Med. -1998 Mar. -Vol. 157. -№ 3 (Ptl). -P. 894−898.
- Durham S. R, Craddock C.F., Cookson W.O. et al. Increases in airway responsiveness to histamine precede allergen-induced late asthmatic responses//! Allergy Clin. Immunol. -1988. -Vol. 82. -P. 764−770.
- Ebeling P.R., Erbas В., Hopper J.L. et al. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids//!. Bone Miner. Res. -1998 Aug. -Vol. 13. -№ 8. -P. 1283−1289.
- Ebina M., Takahashi Т., Chiba T. et al. Cellular hypertrophy & hyperplasia of airway smooth muscle underlying bronchial asthma. A 3-D morphometry study//Am. Rev. Respir. Dis. -1993. -Vol. 148. -P. 720−6.
- Ece F., Есе Т., Yilmaz A. et al. The assessment of the efficacy of salmeterol and beclomethasone dipropionate measuring serum eosinopnil cationic protein levels//Allergy and Asthma. -1996. -Vol. 13. -№ 5. -P. 53.
- Edsbacker S., Andersson P., Lindberg C. et al. Metabolic acetal splitting of budesonide. A novel inactivation pathway for topical glucocorticoids//Drug Metab. Dispos. -1987. -Vol. 15. -P. 412−417.
- Eggleston P., Kaggey-Sobotka A., Proud D. et al. Dissociation of the release of histamine & arachidonic acid metabolites from osmotically activated basophiles & human lung mast cells//Amer. Rev. Respir. Dis. -1990. -Vol. 141. -P. 960−964.
- Eseverri J.L., Botey J., Marin A.M. Budesonide: treatment of bronchial asthma during childhood//Allergy Immunol. Paris. -1995 Apr. -Vol. 27. -№ 4. -P. 129−135.
- Evans D.J., Taylor D. A., Zetterstrom O. et al. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma//N. Engl. J. Med. -1997 Nov. -Vol. 337. -№ 20. -P. 1412−1418.
- Evans M., O’Connor D.J., Fuller R.W. et al. Effect of inhaled budesonide on eosinophil density in asthma//Br. J. Clin. Pharmacol. -1991. Vol. 31. -P. 616.
- Fabbri L.M., Papi A, Corbetta L. et al. The therapy of bronchial asthma/ZRecenti Prog. Med. -1999 May. -Vol. 90. -№ 5. -P. 271−279.
- Fahy J.V., Boushey H.A. Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation//Eur. Respir. J. -1998 Jun. -Vol.11. -№ 6. -P. 12 401 247.
- Fahy J. V., Steiger D.J., Liu J. et al. Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects//Am. Rev. Respir. Dis. -1993 May. -Vol. 147. -№ 5. -P. 1132−1137.
- Fairfax AJ., David V., Douce G. Laryngeal aspergillosis following high dose inhaled fluticasone therapy for asthma//Thorax. -1999 Sep. -Vol. 54. -№ 9. -P. 860−861.
- Falcoz C., Mackie A.E., McDowall J. et al. Oral bioavailability of fluticasone propionate in healthy subjects//Br. J. Clin. Pharmacol. -1996. -Vol. 41. -P. 459−460.
- Faul J.L., Leonard C.T., Burke C.M. et al. Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time//Thorax. -1998 Sep. -Vol. 53. -№ 9. -P. 753−761.
- Feldman D., Funder J., Loose D. Is the glucocorticoid receptor identical in various target organs?//! Steroid Biochem. -1978. -Vol. 9. -P. 141−145.
- Feresia, Bertorelli G., Pesci A. et al. Inflammatory markers in bronchoalveolar lavage and in bronchial biopsy in asthma during remission//Chest. -1990. -Vol. 98. -P. 528 535.
- Ferguson A.C., Spier S., Manjra A. et al. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide//! Pediatr. -1999 Apr. -Vol. 134. -№ 4. -P. 422−427.
- Ferguson A.C., Whitelaw M., Brown H. Correlation of bronchial eosinophils and mast cell activation with bronchial hyperresponsiveness in children with asthma/Д. Allergy Clin. Immunol, -1992. -Vol. 90. -P. 609−613.
- Ferguson A.C., Wong F.W. Bronchial hyperresponsiveness in asthmatic children: correlation with macrophages and eosinophils in bronchoalveolar lavage fluid// Chest. -1999. -Vol. 96. -P. 988−991.
- Ferreira H.H., Bevilacqua E., Gagioti S.M. et al. Nitric oxide modulates eosinophil infiltration in antigen-induced airway inflammation in rats//Eur. J. Pharmacol. -1998 Oct. -Vol. 358. -№ 3. -P. 253−259.
- Flak T.A., Goldman W.E. Autotoxicity of nitric oxide in airway disease//Am. J. Respir. Crit. Care Med. -1996 Oct. -Vol. 154. -№ 4 (Pt2). -P. 202−206.
- Flower R.J., Blackwell G.J. Antiinflammatory steroids induce biosynthesis of a phospholipase Аг inhibitor which prevents prostaglandin generation//Nature. -1979. -Vol.278. -P. 456−459.
- Ford-Hutchinson A.W. Leukotriene involvement in pathologic process//J. Allergy Clin. Immunol. -1984. -Vol. 74. -№ 2. -P. 437−440.
- Frenley D.C. Can today’s treatment prevent tomorrow’s obstruction//Br. J. Clin. Pract. -1988. -Vol. 42. -№ 2. -Suppl. 59. -P. 25−36.
- Friday G.A. Jr., Khine H., Lin M.S. et al. Profile of children requiring emergency treatment for asthma//Ann. Allergy Asthma Immunol. -1997 Feb. -Vol. 78. -№ 2. -P. 221 224.
- Frieri M. Nitric oxide in allergic rhinitis and asthma//Allergy-Asthma-Proc. -1998 Nov-Dec. -Vol. 19. -№ 6. -P. 349−51.
- Fuller R., Johnson M., Bye A. Fluticasone propionate an update on preclinical and clinical experience//Respir. Med. -1995 Sep. -Vol. 89. -Suppl. A. -P. 3−18.
- Gant V., Cluzel M., Shakoor Z. et al. Alveolar macrophage accessory cell function in bronchial asthma//Am. Rev. Respir. Dis. -1998. -Vol. 146. -P. 900−904.
- Garrett J., Williams S., Wong S. et al. Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroids//Arch. Dis. Child. -1998 Jul. -Vol. 79. -№ 1. -P. 12−17.
- Gee M.H., Albertine K.H. Neutrophil-endothelial cell interaction in the lung//Ann. Rev. Physiol. -1993. -Vol. 55. -P. 227−248.
- Gerdtham U.G., Hertzman P., Jonsson B. et al. Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden 1978 to 1991//Med. Care. -1996 Dec. -Vol. 34. -№ 12.-P. 1188−1198.
- Gibson P.G., Mattoli S., Sears M.S. et al. Cellular characteristics of sputum from patients with asthma & chronic bronchitisZZThorax. -1989. -Vol. 44. -P. 693−9.
- Giep Т., Raibble P., Zuerlein T. et al. Trial of beclomethasone dipropionate by metered-dose inhaler in ventilator-dependent neonates less than 1500 grams//Am. J. Perinatol. -1996 Jan. -Vol. 13. -№ 1. -P. 5−9.
- Goldberg S., Algur N., Levi M. et al. Adrenal suppression among asthmatic children receiving chronic therapy with inhaled corticosteroids with and without spacer device//Ann. Allergy Asthma Immunol. -1996 Mar. -Vol. 76. -№ 3. -P. 234−238.
- Gomez F.P., Barbera J.A., Roca J. et al. Effect of nitric oxide synthesis inhibition with nebulized L-NAME on ventilation-perfusion distributions in bronchial asthma//Eur. Respir. J. -1998 Oct. -Vol. 12. -№ 4. -P. 865−871.
- Goodwin A. Treating childhood asthma with nebulised steroids/ZProf. Care Mother Child. -1995. -Vol. 5. -№ 1. -P. 7−9.
- Grandgeorge S., Vaughan L., Milavetz G. et al. Systemic and topical dose-response relationships of inhaled corticosteroids aerosolsZZAnnual Meeting of the American Academy of Allergy and Immunology in Washington. -1987. -Vol. 883. -P. 64−7.
- Griese M., Schur N., Laryea M.D. et aLZZEurop. J. Pediatr. -1990. -Vol. 149. -№ 7. -P. 508−512.
- Grootendorst D.C., Sont J.K., Wfflems L.N. et al. Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsiesZZClin. Exp. Allergy. -1997 Jul. -Vol.27. -№ 7. -P- 769−779.
- Gross N.J. Anticholinergic therapy in obstructive airway disease, -London: Franklin Scientific Publ., 1993. -19−23 p.
- Grossman A. Steroid safety: the endocrinologist’s viewZZInt. J. Clin. Pract. Suppl. -1998 Sep. -Vol. 96. -P. 33−38.
- Grydlewski R.J. Transcellular biosynthesis of eicosanoidsZ/Pol. J. Pharmacol. -1999 Mar-Apr. -Vol. 51. -№ 2. -P. 113−117.
- Guo F.H., Comhair S.A., Zheng S. et al. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis//! Immunol. -2000 Jun. -Vol. 164. -№ 11. -P. 5970−5980.
- Haapasaari K., Rossi O., Risteli J. et al. Effects of long-term inhaled corticosteroids on skin collagen synthesis and thickness in asthmatic patients//Eur. Respir. J. -1998 Jan. -Vol.11. -№ 1. -P. 139−143.
- Ha-Baik Lee, Jae Won Oh, Ji Hye Kim. Elevated circulating levels of ECP, ICAM-1, VCAM-1, IL-6 and IL-6 receptor and the beneficial effects of inhaled budesonide in children wish asthma//Allergy and Asthma. -1996. -Vol. 16. -№ 5. -P. 28.
- Hagan J.B., Kita H., deich G.J. Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: comparison with other glucocorticoids//Clin. Exp. Allergy. -1998 Aug. -Vol. 28. -№ 8. -P. 999−1006.
- Haley K.J. Inflammation & airway function in asthma//Am. J. Respir. Crit. Care Med. -1998. -Vol. 157. -P. 1−3.
- Hamada H., Sakatani M., Ueda E. KL-6 in patients with interstitial pneumonitis//Nihon Kyoby Shikkan Gakkai Zasshi. -1996 Jul. -Vol. 34. -№ 7. -P. 771−777.
- Hamid Q., Springall D.R., Riveros-Moreno V. et al. Induction of nitric oxide synthase in asthma/ZLancet. -1993. -Vol. 342. -P. 1510−1513.
- Harding S.M. The human pharmacology of fluticasone propionate/ZRespir. Med. -1990. -Vol. 84 (Suppl. A). -P. 25−29.
- Hasegawa S. Clinical significance of serum levels of a carbohydrate antigen, syalyl antigen SSEA-1, in patients with fibrosing lung disease//Am. Rev. Respir. Dis. -1991. -Vol. 144.-P. 1177−1181.
- Hashimoto Т., Minoguchi K., Kohno Y. et al. Correlation between respiratory function and airway inflammation in asthma/ZInt. Arch. Allergy Immunol. -1999. -Vol. 120, Suppl. 1. -P. 82−85.
- Henderson W.R. Jr., Lewis D.B., Albert R.K. et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma/ZJ. Exp. Med. -1996 Oct. -Vol. 184. -№ 4. -P. 1483−1494.
- Herd C.M., Page C.P. Pulmonary immune cells in health & disease: platelets//Eur. Respir. J. -1994. -Vol. 7. -P. 1145−1160.
- Herraia J., Puolijoki H., Imprivaara O. et al. Bone mineral density in asthmatic women of high-dose inhaled beclomethasone dipropionate//Bone. -1994. -Vol. 15. -№ 6. -P, 621−623.
- Hilgers J., Von Mensdorff—Poully S., Verstraeten A.A. et al. Quantitation of polymorphic epithelial mucin: a challenge for biochemists and immunologist//Scand. J. Clin. Lab. Invest. 1995. -Vol. 55, Suppl. 221. -P. 81−86.
- Hirata F., Schiffinan E., Venkatasubramanian K. et al. A phospholipase A2 inhibitory protein in rabbit neutrophilis induced by g (ucocorticoids//Proc. Natl. Acad. Sci. USA -1980. -Vol. 77. -P. 2533−2536.
- Hirst S.J., Lee Т.Н. Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma//Am. J. Respir. Crit. Care Med. -1998 Nov. -Vol. 158. -№ 5 (Pt 3). -P. 201−206.
- Hodge W.Y., Whitcher J.P., Satariano W. Risk factors for age-related cataracts/ZEpidemiol. Rev. -1995. -Vol. 17. -P. 336−346.
- Hoekstra M.O., Grol M.H., Bouman K. et al. Fluticasone propionate in children with moderate asthma//Am. J. Respir. Crit. Care Med. -1996 Oct. -Vol. 154. -№ 4 (Ptl). -P. 1039−1044.
- Hoekstra M.O., Grol M.H., Hovenga H. et al. Eosinophil and mast cell parameters in children with stable moderate asthma/ZPediatr. Allergy Immunol. -1998 Aug. -Vol. 9. -№ 3. -P. 143−149.
- Hoekx J.C., Hedlin G., Pedersen W. et al. Fluticasone propionate compared with budesonide: A double-blind trial in asthmatic children using powder devices at a dosage from 400 mu g/day (-1)//Eur. Respir. J. -1996. -Vol. 9. -№ 11. -P. 2263−2272.
- Hogg J.C. Neutrophil kinetics & lung injury/ZPhysiol. Rev. -1987. -Vol. 67. -P. 1249−1294.
- Hogger P., Rawert I., Rohdewald P. Dissolution, tissue binding and kinetics of receptor binding of inhaled glucocorticoids//Eur. Respir. J. -1993. -Vol. 6. -Suppl. 17. -P. 584.
- Hogman M., Frostell C.G., Hedenstrom H. et al. Inhalation of nitric oxide modulates adult human bronchial tone//Am. Rev. Respir. Dis. -1993. -Vol. 148. -P. 14 711 478.
- Holgate S. Is asthma an inflammatory disease//Eur. Respir. Dis. -1994. -Vol. 4. -Review 24.-P. 388−390.
- Holgate S.T. Mediators and cytokine mechanisms in asthma//Thorax. -1993. -Vol. 48. -P. 103−109.
- Holtzman M.J. Arachidonic acid metabolism//Am. Rev. Respir. Dis. -1991. -Vol. 143. -P. 188−203.
- Honda Y., Kuroki Y., Matsuura E. et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids/Mm. J. Respir. Crit. Care Med. -1995. -Vol. 152. -P. 1860−1866.
- Hone S.W., Donnelly M.J., Robertson J. et al. Dysphonia and inhalation of corticoids: a prospective study//Rev. Laryngol. Otol. Rhinol. Bord. -1996. -Vol. 117. -№ 4. -P.331−333.
- Hong S.L., Levine L. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids//Proc. Natl. Acad. Sci. USA -1976. -Vol.73. -P. 1730−1734.
- Honour J.W., Kelnsr C.J.H., Brook C.G.D. Urine steroid excretion rates in childhood reflect growth and activity of adrenal cortex//Acta Endocrinol. -1990. -Vol. 14. -P. 219−224.
- Hopp R.J., Degan J.A., Biven R.E. et al. Longitudinal assessment of bone mineral density in children with chronic asthma//Ann. Allergy Asthma Immunol. -1995. -Vol. 75. -P. 143−148.
- Horn C.R., Clark T.J., Cochrane G.M. Inhaled therapy reduces morning dips in asthma/ZLancet. -1984. -Vol. 1. -P. 1143−1145.
- Horwath J., Huszr E., Barath E. et al. Nitric oxide synthase inhibitors influence pulmonary cGMP levels in the guinea pig//Eur. Respir. J (Abstr. ERS Ann. Congrs.). -1996. -№ 0183. -P. 13−14.
- Hoshino M., Nakamura Y. Anti-inflammatory effects of inhaled beclomethasone dipropionate in nonatopic asthmatics//Eur, Respir. J. -1996 Apr. -Vol. 9. -№ 4. -P. 696−702.
- Hoshino M., Sim J., Shimizu K. et al. Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma//! Allergy Clin. Immunol. -1999 Jun. -Vol. 103. -№ 6. -P. 1054−1061.
- Howarth P. The airway inflammatory response in allergic asthma & its relationship to clinical disease//AHergy. -1995. -Vol. 50. -Suppl. 27. -P. 13−21.
- Huang J., Olivenstein R., Taha R. et al. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics//Am. J. Respir. Crit. Care Med. -1999 Aug. -Vol.160. -№ 2. -P. 725−729.
- Hudon C., Turcotte H., Laviolette M. et al. Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction//Ann. Allergy Asthma Immunol. -1997 Feb. -Vol. 78. -№ 2. -P. 195−202.
- Ikuta N., Kondoh Y., Tangiguchi H. et al. Effect of long-term treatment with an inhaled corticosteroids on bronchial hyper-responsiveness and clinical asthma in asthmatic subjects/'/Arerugi. -1996 Dec. -Vol. 45. -№ 12. -P. 1231−1236.
- Imai Т., Adachi M. Inhaled corticosteroid therapy in long-term management of adult asthma//Nippon-Rinsho. -1996 Nov. -Vol. 54. -№ 11. -P. 2969−2975.
- Ip M., Lam K., Yam L. et al Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroid//Chest. -1994. -Vol. 105. -P. 17 221 727.
- Ishihara K., Hasegawa Т., Nishimura T. et al. Increased use of inhaled corticosteroids and reduced hospitalizations in adult asthmatics: 11 years' experience in Japanese hospital/ZRespirology. -1998 Sep. -Vol. 3. -№ 3. -P. 193−7.
- Ishioka S., Haruta Y., Hozawa S. et al. Effect of Leukotriene receptor antagonist, ONO-1078, on serum eosinophil cationic protein in patients with bronchial asthma//Allergy and Asthma. -1996. -Vol. 16. -№ 5. -P. 50.
- Jackson L.D., Polygenis D., Mclvor R.A. et al. Comparative efficacy and safety of inhaled corticosteroids in asthma//Can. J. Clin. Pharmacol. -1999. -Vol. 6. -№ 1. -P. 2637.
- Jaffiiel D., Mathieu M., Torado-de-la-Fuente P. et al. Corticoid therapy and bronchial inflammation in asthma. The use of bronchial biopsy//Rev. Mai. Respir. -1998 Jun. -Vol. 15. -№ 3. -P. 225−238.
- Jain В., Lubinstein I., Robbins F.A. et al. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide//Biochem. Biophys. Res. Commun. -1993. -Vol. 191. -P. 83−88.
- Jang A.S., Choi I.S. Nitric oxide metabolites in patients with asthma: induced sputum versus blood/ZRespir. Med. -1999 Dec. -Vol. 93. -№ 12. -P. 912−918.
- Jarvis В., Faulds D. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dasages < or = 500 microg/day in adults and adolescents with mild to moderate asthma/ZDrugs. -1999 May. -Vol. 57. -№ 5. -P. 769−803.
- Jatakanon A., Kharitonov S., Lim S. et al. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma//Thorax. -1999 Feb. -Vol. 54. -№ 2. -P. 108−114.
- Jatakanon A., Lim S., Chung K.F. et al. An inhaled steroid improves markers of airway inflammation in patients with mild asthma//Eur. Respir. J. -1998 Nov. -Vol. 12. -№ 5. -P. 1084−1088.
- Jeflfery P.K., Godfrey W., Adelroth. et al. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma//Am. Rev. Respir. Dis. -1992. -Vol. 145. -P. 890−899.
- Joos G.F., Germonpre P.R., Pauwels R.A. Neural mechanisms in asthma//Clin. Exp. Allergy. -2000 Jun. -Vol. 30. -Suppl. 1. -P. 60−65.
- Kacmarek R.M., Ripple R., Cockrill B.A. et al. Inhaled nitric oxide. A bronchodilatator in mild asthmatics with methacholine-induced bronchospasm//Am. J. Respir. Crit. Care Med. -1996 Jan. -Vol. 153. -№ 1. -P. 128−135.
- Kaminsky D. A, Mitchell J., Carroll N. et al. Nitrotyrosine formation in the airways and lung parenchyma of patients with asthma//J. Allergy Clin. Immunol. -1999 Oct. Vol. 104. -№ 4 (Ptl). -P. 747−754.
- Kanazawa H., Shoji S., Yoshikawa T. et al. Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease//Clin. Exp. Allergy. -1998 Oct. -Vol. 28. -№ 10. -P. 1244−1250.
- Karim A.K., Jacob T.J., Thompson G.M. The human lens epithelium: morphological and ultrastructural changes associated with steroid therapy//Exp. Eye Res. -1989. -Vol. 48. -P. 215−224.
- Kathleen J. Haley, Jeffrey M. Drazen. Inflammation and airway function in asthma. What You see is not necessarily what You get//Am. J. Respir. Crit. Care Med. -1998. -Vol. 157. -P. 1−3.
- Kay A. Asthma & inflammation//J. Allergy Clin. Immunol. -1991. -Vol. 87. -P. 893−910.
- Kelly C., Ward C., Stenton C. Numbers & activity of inflammatory cells in BAL fluid in asthma & their relation in airway responsiveness//Thorax. -1998. -Vol. 43. -P. 68 492.
- Kelso T.M., Abou-Shala N., Heilker G.M. et al. Comprehensive long-term management program for asthma: effect on outcomes in adult African-Americans//Am. J. Med. Sci. -1996 Jun. -Vol. 311. -№ 6. -P. 272−280.
- Kerby J., Hargreave F., Gleich G et al. Bal cell profiles of asthmatic & nonasthmatic subjects//Amer. Rev. Respir. Dis. -1987. -Vol. 136. -P. 379−383.
- Kerrebijn K.F., van Ess Zandvliet E.M., Neijens H.J. et al Effects of long-term treatment with inhaled corticosteroids and p2-agonists on the bronchial responsiveness in children with asthma//J. Allergy Clin. Immunol. -1987. -Vol.79. -P. 653−569.
- Kharitonov S.A., O’Connor B.J., Evans D.J. et al. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide//Am. J. Respir. Crit. Care Med. -1995. -Vol. 151. -P. 1894−1899.
- Kharitonov S.A., Yates D., Robbins R.A. et al. Increased nitric oxide in exhaled air of asthmatic patients//Lancet. -1994. -Vol. 343. -P. 133−135.
- Kirby J. G., Hargreave F.E., Gleich G.J. et al. Bronchoalveolar cell profiles asthmatic and nonasthmatic subjects//Am. Rev. Respir. Dis. -1997. -Vol. 136. -P. 379−383.
- Kirsten A.M., Jorres R.A., Kirsten D. et al. Comparison of nasal and bronchial production of nitric oxide in healthy probands and patients with asthma/ZPneumologie. -1997 Apr. -Vol. 51. -№ 4. -P. 359−364.
- Kitamura S., Hiwada K., Kobayashi J. et al. Use of the ED046 kit to analyze serum KL-6 in patients with pneumonitis//Nihon Kyoby Shikkan Gakkai Zasshi. -1996 Jun. -Vol. 34. -№ 6. -P. 639−645.
- Kitamura S., Sugama Y. The management of chronic asthma with inhaled beta 2 agonists regular use? symptomatic use?//Nippon-Rinsho. -1996 Nov. -Vol. 54. -№ 11. -P. 3078−3080.
- Kleerup E.C. Bronchodilators: new drugs and controversies//Curr. Opin. Pulm. Med. -1997 Jan. -Vol.3. -№ 1. -P. 17−22.
- Klickstein L.B., Shapleigh C., Goetzl E.J. Lypoxygenation of arachidonic acid as a source of PMN leukocyte chemotactic factors in sinovial fluid and tissue in rheumatoid arthritis and spondiloarthritis//J. Clin. Invest. -1980. -Vol. 66. -P. 1166−1170.
- Kobayashi J., Kitamura S. How can we monitor and treat patients with acute exacerbations of idiopathic interstitial pneumonia/ZNihon Kyoby Shikkan Gakkai Zasshi. -1996 Dec.-Suppl. 34.-P. 195−199.
- Kobayashi J., Kitamura S. KL-6: a serum marker for intersitial pneumonia//Chest. -1995.-Vol. 108.-P. 311−315.
- Kobayashi J., Kitamura S. Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis//Chest. -1996 May. -Vol. 109. -№ 5. -P. 1276−1282.
- Kobayashi J., Tsukagoshi M., Hagiwara S. et al. Hypersensitivity pneumonitis monitored with serum KL-6, a marker of interstitial pneumonia//Nihon Kyoby Shikkan Gakkai Zasshi. -1996 Jul. -Vol. 34. -№ 7. -P. 837−842.
- Kohno N. Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia//Nihon Kyoby Shikkan Gakkai Zasshi. -1996 Dec. -Suppl. 34. -P. 186−189.
- Kohno N., Awaya Y., Oyama T. et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease//Am. Rev. Respir. Dis. -1993 Sep. -Vol. 148. № 3. -P. 637−642.
- Kohno N., Kyoizumi S., Awaya Y. et al. New serum indicator of intersitial pneumonitis activity: sialyated carbohydrate antigen KL-6//Ibid. -1989. -Vol. 96. -P. 68−73.
- Kolaczkowska M., Mlynarczyk W., Rzymkowska M. Long-term corticosteroid therapy as a risk factor of osteoporosis in patients with asthma and chronic bronchitisZZPneumonol. Alergol. Pol. -1996. -Vol. 64. -№ 3−4. -P. 196−203.388.
- Konig P. Evidence for benefits of early intervention with non-steroidal drugs in asthmaZZPediatr. Pulmonol. -1997. -Suppl. 15. -P. 34−39.
- Konig P., Shaffer J. The effect of drug therapy on long-term outcome of childhood asthma: a possible preview of the international guidelines//!. Allergy Clin. Immunol. -1996 Dec. -Vol. 98. -№ 6(Ptl). -P. 1103−1111.
- Kraft M., Wenzel S.E., Bettinger C.M. et al. The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma//Chest. -1997 may. -Vol. 111. -№ 5. -P. 1249−1254.
- Kudo K. High dose inhaled steroid therapy usefulness and limitationZZNippon-Rinsho. -1996 Nov. — Vol. 54. -№ 11. -P. 2993−2997.
- Kuitert L.M., Newton R., Barnes N.C. et al. Eicosanoid mediator expression in mononuclear and polymorphonuclear cells in normal subjects and patients with atopic asthma and cystic fibrosis/ZThorax. -1996 Dec. -Vol. 51. -№ 12. -P. 1223−1228.
- Kumar A., Busse W.W. Clinical aspects of anti-inflammatory therapy in asthmaZZCurr. Opin. Pulm. Med. -1996 Jan. -Vol. 2. -№ 1. -P. 40−47.
- Laitinen A., Altraja A., Kampe M. et al. Tenascin is increased in airway basement membrane of asthmatics and decreased by inhaled steroid//Am. J. Respir. Crit. Care Med. -Vol. 1997 Sep. -Vol. 156. -№ 3 (Ptl). -P. 951−958.
- Laitinen L., Laitinen A. Structural & cellular changes in asthma//Eur. Respir. Rev. -1994. -Vol. 4. P. 348−351.
- Laitinen L., Laitinen A. Structural & cellular changes/ZEpithelial pathology in asthma a target for drug therapyZZAstra satellite symposium at the 3 ERS Congress, Firenze, September 26. -1993. -P. 4−5.
- Laitinen L., Laitinen A., Haahtata T. Airway mucosa inflammation even in patients with newly diagnosed asthmaZZAm. Rev. Respir. Dis. -1993. -Vol. 147. -P. 697 704.
- Lam S., Le Riche J., Phillips D. et al. Cellular & protein changes in bronchoalveolar lavage fluid after late asthmatic reactions in patients with red cedar asthma//J. Allergy Clin. Immunol. -1987. -Vol. 80. -P. 44−50.
- Lane S. J., Lee Т.Н. Cellular and molecular mechanisms of glucocorticoid-resistant asthma//Atemwegs-und Lungenkrankh. -1997. -Vol. 23. -№ 7. -P. 362.
- Larsen B.B., Dahl R. Do inhaled steroids have similar efficacy? A case of bronchial asthma suggesting different efficacy of inhaled glucocorticosteroids//Allergy. -1995 Jul. -Vol. 50. -№ 7. -P. 600−603.
- Le Merre C., Bengtsson Т., Bretecher P. et al. Effect on lung function and inflammatory markers of single-doses of inhaled budesonide in asthmatics//Allergy and Asthma. -1996. -Vol. 16. -№ 5. -P. 54.
- Ledford D., Apter A., Brenner A.M. et al. Osteoporosis in the corticosteroid-treated patients with asthma//J. Allergy Clin. Immunol. -1998. -Vol. 102. -№ 3. -P. 353−362.
- Leikauf G.D., Driscoll K.E., Wey H.E. Ozone-induced augmentation of eicosanoid metabolism in epithelial cells from bovine trachea//Am. Rev. Respir. Dis. -1988. -Vol. 137. -P. 435−442.
- Levy J. Effect of prolonged use of inhaled steroids on the cellular immunity of children with asthma//J. Allergy Clin. Immunol. -1995. -Vol. 95. -P. 806−812.
- Levy J., Zalkinder I., Kuperman O. et al. Effect of prolonged use of inhaled steroid in the cellular immunity of children with asthma//Ibid. -1996. -Vol. 95. -№ 4. -P. 806−812.
- Levy M.L., Stevenson C., Maslen T. Comparison of short courses of oral prednosolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care//Thorax. -1996 Nov. -Vol. 51. -№ 11. -P. 1087−1092.
- Lewis R.A., Austen K.F. Molecular determinants for functional responses to the sulfidopeptide leukotrienes: metabolism and receptor subclasses//! Allergy Clin. Immunol. -1984. -Vol. 74. -P. 369−373.
- Lonnebo A., Grahnen A., Jansson B. et al. An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers//Eur. J. Clin. Pharmacol. -1996. -Vol. 49. -№ 6. -P. 459−463.
- Lonnebo A., Grahnen A., Ling-Andersson A. et al. A comparison of the effects on the HPA-axis of single and repeated doses of inhaled fluticasone propionate and BUD//Am. J. Respir. Crit. Care Med. -1995. -Vol. 151. -№ 4 (Pt2). -P. 375.
- Lou Y.P., Takeyama К., Grattan K.M. et al. Platelet-activating factor induces goblet cell hyperplasia and mucin gene expression in airways//Am. J. Respir. Crit. Care Med. -1998 Jun. -Vol. 157. -№ 6 (Ptl). -P. 1927−1934.
- Luengo M., Picado C., Piera C. et al. Intestinal calcium absorbtion & parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment//Eur. Respir. J. -1991. -Vol. 4. -№ 4. -P. 441−444.
- Mac Donald B.R., Gowen M. Cytokines & bone//Brit. J. Rheumatol. -1992. -Vol. 31. -№ 2. -P. 149−155.
- Mackenzie C.A., Wales J.K.H. Knemometry and its practical application//Eur. Respir. J. -1993. -Vol. 3. -№ 13. -P. 321−325.
- Mackie AE., Ventresca G.P., Moss J.A. et al. Pharmacokinetics of intravenous fluticasone propionate in healthy subjects//Br. J. Clin. Pharmacol. -1995. -Vol. 40. -P. 198.
- Madden V. Asthma: how early to start using inhaled steroids?//Prof. Care Mother Child. -1887. -Vol. 7. -№ 1. -P. 21−22.
- Malo J.L., Carrier A., Cote J. et al. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: a 18-month double-blind crossover study//Am. J Respir. Crit. Care Med. -1996 Mar. -Vol. 153. -№ 3. -P. 953−960.
- Mansour M., Farouk N., el-Maragy A. et al. Elevated plasma level of leukotrienes in bronchial asthma patients- a possible clinical relevance//Dis. Markers. -1995 Mar. -Vol. 12. -№ 2. -P. 117−122.
- Maria G., Bellofiore S., Ciancio N. et al. Platelet activating factor increases airway reactivity but not maximal bronchoconstriction to methacholine in normal subjects//Europ. Respir. J. -1993. -Vol. 6. -S. 17. -P. 0854.
- Marom Z., Shelhamer J.H., Bach M.K. et al. Slow reacting substances, LTC4 and D4 increase the release of mucus from human airway in vitro//Am. Rev. Respir. Dis. -1982. -Vol. 126. -P. 449−451.
- Martin T.R., Ranji G., Merrit T.L. et al. Relactive contribution of LTB4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophages//!. Clin. Invest. -1987. -Vol. 80. -P. 1114−1129.
- Martinati L.C., Bertoldo F., Gasperi E. et al. Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma//Am. J. Respir. Crit. Care Med. -1996. -Vol. 153. -№ 1. -P. 232−236.
- Martinez F.D. Present and future treatment of asthma in infants and young children//! Allergy. Clin. Immunol. -1999 Oct. -Vol. 104. -№ 4 (Pt2). -P. 169−174.
- MasGlashan D., Schleimer R.P., peters S.P. Generation of leukotrienes by purified human lung mast cells//! Clin. Invest. -1982. -Vol.70. -P. 747−751.
- Massaro A.F., Gaston В., Kita D. et al. Expired nitric oxide levels during treatment of acute asthma//Am. J. Respir. Crit. Care Med. -1995 Aug. -Vol. 152. -№ 2. -P. 800−803.
- Matsumoto K., Taki F., Miura M. et al. Serum levels of soluble IL-2R, IL-4 & soluble Fc ER П in adult bronchial asthma//Chest. -1994. -Vol. 105. -P. 681−686.
- Mattes J., Storm-van's-Gravesande K., reining U. et al. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma//Eur. Respir. J. -1999 Jun. -Vol. 13. -№ 6. -P. 1391−1395.
- Mautino G., Henriquet C. n Gougat C. et al. Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteibase-9 by macrophages in asthma//Lab-Invest. -1999 Jan. -Vol. 79. -№ 1. -P. 39−47.
- Mc Leod J.F. Osteoporosis, cytokines & glucocorticoids//Allergy Proc. -1993. -Vol. 14. -№ 5. -P. 363−364.
- McFadden E.R. Inhaled glucocorticoids and acute asthma: therapeutic breakthrough or nonspecific effect?//Am. J. Respir. Crit. Care Med. -1998 Mar. -Vol. 157. -№ 3 (Ptl). -P. 698−703.
- Meltzer E.O., Kemp J.P., Orgel H.A. et al. Flunisolide aerosol for treatment of severe, chronic asthma in steroid-independent children/ZPediatrics. -1982. -Vol. 69. -P. 340.
- Messer J.W., Peters G.A., Bennet W.A. et al. Causes of death & pathologic findings in 304 cases of bronchial asthma//Dis. Chest. -1960. -Vol. 38. -P. 612−24.
- Metzger W., Zavala D., Richerson H. et al. Local allergic challenge & bronchoalveolar lavage in allergic asthmatic lungs: description of the model & local allergic inflammation//Am. Rev. Respir. Dis. -1987. -Vol. 135. -P. 433−440.
- Michael Y. Viksman, Mark C. Liu, Carol A. Bickel et al. Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation//Am. J. Respir. Crit. Care Med. -1997. -Vol. 166. -P. 858−863.
- Michel F.B., Chanez P. Asthma and corticosteroid therapy//Presse-Med. -1996 Mar. -Vol. 25. -№ 9. -P. 436−437.
- Milanowski J., Qualtrough J., Perrin V.L. Inhaled beclomathasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma//Respir. Med. -1999 Apr. -Vol. 93. -№ 4. -P. 245−251.
- Mita H., Yui Y., Taniguchi N. et al. Increased activity of 5-lipoxygenase in PMN leukocytes from asthmatic patients//Life Sci. -1985. -Vol. 37. -P. 907−914.
- Mitsunobu F., Mifiine Т., Hosaki Y. et al. Different roles of histamine and leukotriene C4 in the airways between patients with atopic ana nonatopic asthma//! Asthma. -1998. -Vol. 35. -№ 4. -P. 367−372.
- Moreno R.H., Hogg J.C., Pare P.D. Mechanics of airway narrowing//Am. Rev. Respir. Dis.-1985.-Vol. 133 -P. 1171−1180.
- Nagai H., Tanaka I- fhe role of cytokines and arachidonic acid metabolites in the development of airway hyperresposiveness//Nippon-Yakurigaku-Zasshi. -1998 Apr. -Vol. 111.-№ 4.-P. 233−41.
- Nasser S.M., Pfister R., Christie P. E et al. Inflammatory cell population in bronchial biopsies from aspirin-sensitive asthmatic subjects//Am. J. Respir. Crit. Care Med. -1996 Jan. -Vol. 153. -№ 1. -P. 90−96.
- Nassif E., Weinberger M., Sherman B. et al. Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma//J. Allergy Clin. Immunol. -1987. -Vol. 80. -P.518−529.
- Nathan R. A, Pinnas J.L., Schwartz H.J. et al. A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma//Ann. Allergy Asthma Immunol. -1999 Jun. -Vol.82. -№ 6. -P. 521−529.
- Nelson B.V., Sears S., Woods J. et al. Expired nitric oxide as a marker for childhood asthma//! Pediatr. -1997 Mar. -Vol. 130. -№ 3. -P. 423−427.
- Nelson H.S. New developments in bronchodilator therapy//Curr. Opin. Pulm. Med. -1996 Jan. -Vol. 2. -№ 1. -P. 35−39.
- Nikolaizik W.H., Preece M.A., Warner J.O. One year follow-up study of endocrine and lung function of asthmatic children on inhaled budesonide//Eur. Respir. J. -1997 Nov. -Vol. 10. -№ 11. -P. 2596−2601.
- Ninan Т.К., Russel G. Asthma, inhaled corticostetoids treatment, and growth//Arch. Dis. Child. -1992. -Vol. 67. -№ 6. -P. 703−705.
- O’Byrne P. What’s new in mediators & mediator antagonists?//Eur. Respir. Rev. -1994. -Vol. 4. -Review 24. -P. 399−401.
- O’Sullivan S. On the role of PGD2 metabolites as markers of mast cell activation in asthma//Acta Physiol. Scand. Suppl. -1999 Apr. -Vol. 644. -P. 1−74.
- Ollerenshaw S.L., Woelcock A.J., Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow inflammation//Am. Rev. Respir. Dis. -1S92. -Vol. 145. -P. 922−927.
- Orsida B.E., Li X., Hickey B. et al. Vascularity in asthmatic airways: relation to inhaled steroid dose//Thorax. -1999 Apr. -Vol. 54. -№ 4. -P. 289−295.
- Oyama Т., Kohno N., Yokoyama A. et al. Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin//Lung. -1997. -Vol. 175. -№ 6. -P. 379−385.
- Park С., Lee S., Sung Wham Chung et al. Interleukin-2 & soluble interleukin-2 receptors in bronchoalveolar lavage fluid patients with bronchial asthma//Chest. -1994. -Vol. 106. -P. 400−6.
- Paterson J.W., Lulich K.M., Goldie R.G. Pharmacology of asthma treatment: an overview//Med. J. Aust. -1995. -Vol. 162. -№ 1. -P. 42−43.
- Pauwels R. Asthma-managing the underlying disease//Eur respir rev. -1994.-№ 4 (review 21). -P. 291−4.
- Pedersen В., Dahl R., Karlstrom R. et al. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking//Am. J. Respir. Crit. Care Med. -1996 May. -Vol. 153. -№ 5. -P. 1519−1529.
- Pedersen S., O’Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma//Allergy. -1997. -Vol. 52. -Suppl. 39. -P. 1−34.
- Pedersen S., Szefler S. Pharmacological interventions. Childhood asthma//Eur. Respir. J. Suppl. -199S Jul. -Vol. 27. -P. 40−45.
- Peters S. Mast cells & histamine in asthma//! Allergy Clin. Immunol. -1990. -Vol. 86. -P. 642−646.
- Petersen W., Karup-Pedersen F., Friis В et al. Sodium cromoglycate as a replacement for inhaled corticosteroids in mild-to-moderate childhood asthma//Allergy. -1996 Dec. -Vol. 51. -№ 12. -P. 870−875.
- Petty T. L. Early identification and intervention in chronic obstructive pulmonary disease//Lung respir. -1993. -Vol. 10. -P. 2−3.
- PfefFer K.D., Ellison G., Robertson D. et al. The effect of inhaled nitric oxide in pediatric asthma//Am. J. Respir. Crit. Care Med. -1996 Feb. -Vol. 153. -№ 2. -P. 747−751.
- Phillipps G.H. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate//Respir. Med. -1990. -Vol. 84. -Suppl. A. -P. 19−23.
- Picado C., Deulofeu R., Lleonart R. et al. Lipid and protein metabolism in asthma. Effects of diet and corticosteroid therapy//Allergy. -1999 Jun. -Vol. 54. -№ 6. -P. 569−575.
- Pieters W.R., Steinmetz K.O., Aubier M. et al. Effectiveness of a new salmeterol/ fluticasone propionate (50/250mcg) combination inhaler in patients with reversible airways obstruction//Eur. Respir. J. -1998. -Vol.12, Suppl. 28. -P. 35s.
- Pincus D.J., Szefler S.J., Ackerson L.M. et al. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy//! Allergy Clin. Immunol. -1995 Jun. -Vol. 95. -№ 6. -P. 1172−1178.
- Piper P.J. Pharmacology of leukotrienes//Br. Med. Bull. -1983. -Vol. 39. -№ 3. -P. 255−259.
- Pirozynski M., Kulaga Z., Kalstrom R. Pulmicort (Budesonide) Turbuhaler in mild to moderate asthma//Allergy and Asthma. -1995. -Vol. 16. -№ 5. -P. 14.
- Polak J.M., Holgate S.T., Howarth P.H. Airway endothelin levels in asthma: influence of endobronchial allergen challenge and maintenance corticosteroid therapy//Eur. Respir. J. -1997 May. -Vol. 10. -№ 5. -P. 1026−1032.
- Ponticiello A., Vatrella A., Parrella R. et al. Inhaled beclomethasone dipropionate (BDP) prevents seasonal changes in atopic asthmatics//Monaldi Arch. Chest Dis. -1997 Apr. -Vol. 52. -№ 2. -P. 112−117.
- Poston R.N., Chanez P., Lacoste J.Y. et al. Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi//Am. Rev. Respir. Dis. -1992. -Vol. 145. -P. 918−921.
- Preice J.F. Inhaled corticosteroids: clinical relevance of safety measures/ZPediatr. Pulmonol. -1997. -Suppl. 15. -P. 40−45.
- Preice J.F., Russel G., Hindmarsh P. et al. Growth velocity in asthmatic children receiving fluticasone propionate 50 meg bd or sodium cromoglycate 20 mg qds//Eur. Respir. J. -1996. -Vol. 9. -Suppl. 23. -P. 294.
- Rajah R., Nachajon R.V., Collins M.K. et al. Elevated levels of the IGF-binding protein protease MMP-1 in asthmatic airway smooth muscle//Am. J. Respir. Cell Mol. Biol. -1999 Feb. -Vol. 20. -№ 2. -P. 199−208.
- Rao R., Gregson R.K., Frederick J.M. et al. Eosinophil markers show changes before improvement in lung function parameters in atopic children with asthma, when treated with inhaled steroids//Allergy & Asthma. -1996. -Vol. 16. -№ 5. -P. 24.
- Raychaudhuri В., Dweik R., Connors M.J. et al. Nitric oxide blocks factor-kappaB activation in alveolar macrophages//Am. J. Respir. Cell Mol. Biol. -1999 Sep. -Vol. 21.-№ 3. P.-311−316.
- Redington A.E. Springall D R., Ghatei M.A. et al. Airway endothelin levels in asthma: influence of endobronchial allergen challenge and maintenance corticosteroid therapy//Eur. Respir. J. -1997 May. -Vol. 10. -№ 5. -P. 1026−1032.
- Redington A.E., Springall D.R., Meng Q.H. et al. Immunoreactive endothelin in bronchial biopsy specimens: increased expression in asthma and modulation by corticosteroid therapy//! Allergy Clin. Immunol. -1997 Oct. -Vol. 100. -№ 4. -P. 544−552.
- Reeves J.T., Stenmark K.R., Voelkel N.F. Possible role of leukotrienes in pathogenesis of pulmonary hypertensive disorders//The Pulmonary circulation and acute lung injury/Ed. S. I. Said. -Mount Kisco: Futura Publ., 1985. p. 337−356.
- Restrick L.J., Sampson A.P., Piper P.J. et al. Reduction in leukotriene B4 generation by bronchoalveolar lavage cells in asthma//Thorax. -1995 Jan. -Vol. 50. -№ 1. -P. 67−73.
- Ricciardolo F.L., Geppetti P., Mistretta A. et al. Randomised double-blind placebo-controlled study of the effect of nitric oxide synthesis in bradykinin-induced asthma/ZLancet. -1996 Aug. -Vol. 348. -№ 9024. -P. 374−377.
- Richman-Eisenstal J., Jorens J., Hebert C. et al. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases//Am. J. Physiol. -1993. -Vol. 264. -P. 413−418.
- Riise G.C., Andersson В., Ahlstedt S. et al. Bronchial brush biopsies for studies of epithelial inflammation in stable asthma and nonobstructive chronic bronchitis//Eur. Respir. J. -1996 Aug. -Vol. 9. -№ 8. -P. 1665−1671.
- Robbins R.A., Barnes P.J., Springall D.R. et al. Expression of inducible nitric oxide synthase in human bronchial epithelial cells//Biochem. Biophys. Res. Commun. -1994. -Vol. 203. -P. 209−218.
- Robinson C.B., Martin W.R., RatlifF J.L. et al. Elevated levels of serum mucin-associated antigen in adult patients with cystic fibrosis//Am. Rev. Respir. Dis. -1993 Aug. -Vol.148. -№ 2. -P. 385−389.
- Rohdewald P., von Eiff M., Wurthwein G. Activation of beclomethasone dipropionate in bronchial secretion and receptor affinities and solubility of inhalative applied glucocorticoids//Atemwegs-Lungenkrankh. -1990. -Vol. 16. -P. 79−84.
- Rohdewald P.J. Comparison of clinical efficacy of inhaled glucocorticoids//Arzneimittelforschung. -1998 Aug. -Vol. 48. -№ 8. -P. 789−796.
- Romain A., Pauwels., Claes-Goran Lofdahl et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma//New Engl. J. Med. -1997. -Vol. 337. -№ 20. -P. 1405−1411.
- Rosenthal R.R., Busse W.W., Kemp J.P. et al. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness//Chest. -1999 Sep. -Vol. 116. -№ 3. -P. 595−602.
- Rossi G.A., Crimi E., Lantero S. et al. The late-phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways//Am. Rev. Respir. Dis. -1991. -Vol. 143. -P. 379−83.
- Ruegsegger P., Medici T.C., Anliker M.//Eur. J. Clin. Pharmacol. -1983. -Vol.25. -P. 615−620.
- Russell G., Williams D.A., Weller P. et al. Salmeterol xinafoate in children on high dose inhaled steroids//Ann. Allergy Asthma Immunol. -1995 Nov. -Vol. 75. -№ 5. -P. 423−428.
- Ryrfeldt A., Andersson P., Edsbacker S. et al. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid//Eur. J. Respir. Dis. -1982. -Vol. 63. -Suppl. 122. -P. 86−95.
- Sabbah A. General considerations on asthma'/Allerg. Immunol. Paris. -1996 Sep. -Vol. 28. -№ 7. -P. 242−245.
- Saetta M., Di Stephano A., Rosina C. et al. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma//Am. Rev. Respir. Dis. -1991. -Vol. 143. -P. 138−143.
- Samhoun M.N., Piper P.J. Actions and interactions of lipoxygenase and cyclooxygenase producte in respiratory and vascular tissue//Prostagland. Leukotr. Med. -1984. -Vol.13. -№ 1. -P. -79−87.
- Sampson A.P., Castling D.P., Green C.P. et al. Persistent increase in plasma and urinary leukotrienes after acute asthma//Acta Dis. Child. -1995 Sep. -Vol. 73. -№ 3. -P. 221 225.
- Sanders S.P. Asthma, viruses, and nitric oxide//Proc. Soc. Exp. Biol. Med. -1999 Mar. -Vol. 220. -№ 3. -P. 123−132.
- Sane A.C., Mendemhall Т., Bass D.A. Secretory phospholipase A2 activity is elevated in bronchoalveolar lavage fluid after ovalbumin sensitization of guinea pigs//J. Leukoc. Biol. -1996 Dec. -Vol. 60. -№ 6. -P. 704−709.
- Sanjiv S., Crotty T.B., Kephart G.M. et al. Sudden-onset fatal asthma//Am. Rev. Respir. Dis. -1993. -Vol. 148. -P. 713−9.
- Schafer D., Schamid M., Gode U.C. et al. Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics//Eur. Respir. J. -1999 Mar. -Vol. 13. -№ 3. -P. 638−646.
- Scher H., Berman D., Weinberg E.G. et al. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy//Clin. Exp. Allergy. -1996 Oct. -Vol. 26.-№io.-P. 1131−1141.
- Schuiling M., Meurs H., Zuidhof A.B. et al. Dual action of iNOS-derived nitric oxide in allergen-induced airway hyperreactivity in conscious, unrestrained guinea pigs//Am. J. Respir. Crit. Care Med. -1998 Nov. -Vol. 158. -№ 5 (Ptl). -P. -1442−1449.
- Sekerel B.E., Tuncer A., Saraclar Y. et al. Inhaled budesonide reduces lung hyperinflation in children with asthma//Acta Paediatr. -1997 Sep. -Vol. 86. -№ 9. -P. 932 936.
- Serhan C.N., Hamberg M., Manuelsson B. Lipoxins. A novel series of compounds formed from arachidonic acid in human leukocytes//Proc. Natl. Acad. Sci. USA. -1984. -Vol. 91. -P. 5335−5339.
- Serrano !, Plaza V., Sanchis J. Hospital admission for asthma. Descriptive analysis and prognostic factors after discharge//Arch. Bronconeumol. -1999 Sep. -Vol. 35. -№ 8. -P. 372−378.
- Shamsuddin M., Chen E., Anderson J. et al. Regulation of leukotriene and platelet-activating factor synthesis in human alveolar macrophages//! Lab. Clin. Med. -1997 Dec. -Vol. 130. -№ 6. -P. 615−626.
- Shapiro G., Bronsky E.A., LaForce C.F. et al. Dose-related efficacy of budesonide administrated via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma//! Pediatr. -1998 Jun. -Vol. 132. -№ 6. -P. 976−982.
- Shaver J.R., Zangrilli J., cirelli K. A et al. Regular inhaled beta2-agonist treatment of allergic asthmatics causes loss of broncho-protection vs methacholine without altering inflammatory responses//Allergy and Asthma. -1995. -Vol. 16. -№ 5. -P. 17.
- ShefFer A.L., LaForce C., Chervinsky P. et al. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group//! Fam. Pract. -1996 Apr. -Vol. 42. -№ 4. -P. 369−375.
- Sherrington C.A., Mallol J. Early effects of inhaled steroids on airway hyperreactivity and pulmonary function in asthma//Pediatr-Pulmonol .-1999 Jun. -Vol. 27. -№ 6. -P. 376−382.
- Shi H., Yokoyama A., Kohno N. et al. Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice//Eur. Respir. Dis. -1998 Mar. -Vol. 11. -№ 3. -P. 624−629.
- Shindo K., Fukumura M., Miyakawa K. Leukotriene B4 levels in the arterial blood of asthmatic patients and the effects of prednisolone//Eur. Respir. Dis. -1995 Apr. -Vol. 8. -№ 4. -P. 605−610.
- Shindo K., Koide K., Fukumura M. Enhancement of Leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor//Thorax. -1997 Dec. -Vol. 52. -№ 12. -P. 1024−1029.
- Shindo K., Koide K., Fukumura M. Platelet-activating factor increases Leukotriene B4 release in stimulated alveolar macrophages from asthmatic patients//Eur. Respir. J. -1998 May. -Vol. 11. -№ 5. -P. 1098−1104.
- Simons F.E. Benefits and risks of inhaled glucocorticosteroids in children with persistent asthma//! Allergy Clin. Immunol. -1998 Nov. -Vol. 102. -№ 5. -P. 77−84.
- Simons F.E. Inhaled glucocorticoids in children: A favourable therapeutic index//Can. Respir. J. -1999 Mar-Apr. -Vol. 6. -№ 2. -P. 175−178.
- Simons F.E.R., Persaud M.P., Gillespie C.A. et al. Absence of posterior subcapsular cataracts in young patients treated with inhaled corticosteroids/ZLancet. -1993. -Vol. 342. -P. 776−778.
- Skoner D.P. Risk/benefit ratio of inhaled steroids//! Pediatr. -1996. -Vol. 129. -№ 6. -P. 942.
- Smeenk F.W., Klinkhamer P.J., Breed W. et al. Opportunistic lung infections in patients with chronic obstructive lung disease: a side effect of inhalation corticosteroids?//Ned. Tijdschr. Geneeskd. -1996 Jan. -Vol. 140. -№ 2. -P. 94−98.
- Sont J.K., Han J., van-Krieken J.M. et al. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids//Thorax. -1996 May. -Vol. 51. -№ 5. -P. 496−502.
- Sorva R, Tahtela R., Turpeinen M. et al. Changes in bone markers in children with asthma during inhaled budesonide and nedocromil treatments//Acta Paediatr. Int. J. Paediatr. -1996. -Vol. 85. -№ 10. -P. 1176−1180.
- Sousa A.R., Trigg C.J., Lane S.J. et al. Effect of inhaled glucocorticoids on IL-1 beta and IL-1 receptor antagonist (IL-1 ra) expression in asthmatic bronchial epithelium//Thorax. -1997 Mar. -Vol. 52. -№ 5. -P. 407−410.
- Spahn J.D., Leung D.Y. The role of glucocorticoids in the management of asthma//Allergy Asthma Proc. -1996 Nov-Dec. -Vol. 17. -№ 6. -P. 341−350.
- Spahn J.D., Leung D.Y., Szefler S.J. New insights into the pathogenesis and management of steroid-resistant asthma//J. Asthma. -1997. -Vol. 34. -№ 3. -P. 177−194.
- Spencer C.M., Jarvis B. Salmeterol/fluticasone propionate combination// Drugs. 1999 Jun. -Vol. 57. -№ 6. -933−940.
- Springall D.R., Meng Q., Redington A. et al. Inducible nitric oxide synthase in asthmatic airway epithelium is reduced by corticosteroid therapy//Am. J. Respir. Crit. Care Med. -1995. -Vol. 151. -P. 833.
- Storr J., Berell E., Barry W. et al. Effect of single dose of prednisolone in acute childhood asthma//Lancet. -1997- ii. -P. 879−881.
- Strausi J. Pathomorphology of the airways in asthma//Acta Microbiol. Immunol. Hung. -1998. -Vol.45. -№ 1. -P. 15−18.
- Street M., Mossman T. Functional diversity of T-lymphocytes due to secretion of different cytokine pattern/ZFASEBJ. -1991. -Vol. 5. -P. 171−177.
- Sugaya F., Tanaka H., Sekine k. et al. Neutrophil elastase: a 1 anti-protease inhibitor complex, eosinophil cationic protein and soluble IL-2-receptor in asthma exacerbation//Allergy and Asthma. -1996. -Vol. 16. -№ 5. -P. 45.
- Svedmyr J., Nybery E., Asbrink-Nilsson E. et al. Intermittent treatment with inhaled steroids for deterioration of asthma due to upper respiratory tract infections//Acta Paediatr. -1995. -Vol. 84. -P. 884−888.
- Sy M.L.T., Chin T.W., Nussbaum E. Pneumocystis carinii pneumonia associated with inhaled corticosteroids in an immunocompetent child with asthma//J. Pediatr. -1995. -Vol. 127. -P. 1000−1002.
- Syrbu S., Thrall R.S., Smilowitz H.M. Sequential appearance of inflammatory mediators in rat bronchoalveolar lavage fluid after oleic acid-induced lung injury//Exp. Lung Res. -1996. -Vol. 22. -P. 33−49.
- Szefler S.J. Early intervention for childhood asthma: inhaled glucocorticoids as the «preferred» medication//! Allergy Clin. Immunol. -1998 Nov. -Vol. 102. -№ 5. -P. 719 721.
- Szefler S.J., Boushey H.A., Pearlman D.S., Togias A. et al. Time to onset of effect of fluticasone propionate in patients with astnma//J. Allergy Clin. Immunol. -1999 May. -Vol. 103 (5 Pt 1). -P. 780−8.
- Szefler S.J. Clinical need for a nebulized corticosteroid//J. Allergy Clin. Immunol. -1999 Oct. -Vol. 104. -№ 4 (Pt2). -P. 162−168.
- Takahashi Т., Munakata M., Suzuki I. et al. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis//Am. J. Respir. Crit. Care Med. -1998 Oct. -Vol. 158. -№ 4. -P. 1294−1298.
- Taylor D.A., McGrath J.L., Orr L.M. et al. Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5'-monophosphate in asthma//Thorax. -1998 Jun. -Vol. 53. -№>6. -P. 483−489.
- Ten-Hacken N.H., Dosterhoff Y, Kauffman H.F. et al. Elevated serum interferon-gamma in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation//Eur. Respir. J. -1998 Feb. -Vol. 11. -№ 2. -P. 312−6.
- Terr A.I., Bloch D.A. Trends in asthma therapy in the United States: 1965−1992//Ann. Allergy Asthma Immunol. -1996 Mar. -Vol. 76. -№ 3. -P. 273−281.
- Thomas B.C., Stanhope R., Grant D.B. Impairment growth in children with asthma during treatment with conventional doses of inhaled corticosteroids//Acta Paediatr. Int. J. Paediatr. -1994. -Vol. 83. -№ 2. -P. 196−199.
- Thorsson L., Dahlstrom K., Edsbacker S. et al. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects//Br. J. Clin. Pharmacol. -1997 Feb. -Vol. 43. -№ 2. -P. 155−161.
- Thorsson L., Kallen A., Wiren J-E. et al. Pharmacokinetics of inhaled fluticasone propionate//Am. J. Respir. Crit. Care Med. -1996. -Vol. 153 (Suppl.). -№ 4 (Pt2). -P. 801.
- Tinkelman D.G., Reed C.E., Nelson H.S. et al. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children/ZPediatrics. -1993. -Vol. 92. -P. 64−77.
- Toogood J.H., Baskerville J.C., Jennings B. et al. Influence of dosing frequency & schedule on response of chronic asthmatics to the aerosol steroid budesonide//J. Allergy Clin. Immunol. -1992. -Vol. 72. -P. 288−298.
- Toogood J., Crilly R, Jones G. et al. Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis//Am. Rev. Respir. Dis. -1988.-Vol. 138.-P. 57−61.
- Toogood J.H., Jennings В., Baskerville J. et al. Bronchial Asthma: Mechanisms and Therapeutics, -Eds. E. B. Weiss, M. Stein. -3-rd Ed. -Boston, 193. -818−841 p.
- Toogood J.H., Markov A.E., Baskerville J. et al. Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma//J. Allergy Clin. Immunol. -1993. -Vol. 91. -P. 571−579.
- Tormey V.J., Faul J., Leonard C. et al. A comparison of regular with intermittent bronchodilators in asthma patients on inhaled steroids/Яг. J. Med. Sci. -1997 Oct-Dec. -Vol. 166. -№ 4. -P. 249−252.
- Trescoli C., Ward M.J. Systemic activity of inhaled and swallowed beclomethasone dipropionate and the effect of different inhaler devices/ZPostgrad. Med. J. -1998 Nov. -Vol. 74. -№ 877. -P. 675−677.
- Ulrik C.S. Outcome of asthma: longitudinal changes in lung function//Eur. Respir. J. -1999 Apr. -Vol. 13. -№ 4. -P. 904−918.
- Ulrik C.S. Prognosis and risk factors for bronchial asthma/ZDanish Medical Bulletin. -1998. -Vol. 45. -№ 5. -P. 480−494.
- Urban R.C. Jr., Cotlier E. Corticosteroid-induced cataractsZZSurv. Ophthalmol. -1986.-Vol. 31.-P. 102−110.
- Vachier I., Chiappara G., Vignola A.M. et al. Glucocorticoid receptors in bronchial epithelial cells in asthmaZZAm. J. Respir. Crit. Care Med. -1998 Sep. -Vol. 158. -№ 3. -P. 963−970.
- Van-Aalderen W.M., Sprikkelman A.B., Hoekstra M.O. Is childhood asthma an inflammatory disease? ZZAllergy. -1999. -Vol. 54. -Suppl. 49. -P. 62−67.
- Van-der-Molen Т., Meyboom-de-Jong В., Mulder H.H. et al. Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment//Am. J. Respir. Crit. Care Med. -1998 Jul. -Vol. 158. -№ 1. -P. 121−125.
- Van-der-Velden V.H. Glucocorticoids: mechanisms od action and antiinflammatory potential in asthma//Mediators Inflamm. -1998. -Vol. 7. -№ 4. -P. 229−237.
- Van-Ganse E., Hubloue I., Vincken W. et al. Actual use of inhaled corticosteroids and risk of hospitalization: a case-control study//Eur. J. Clin. Pharmacol. -1997. -Vol. 51. -№ 6. -P. 449−454.
- Van-Ganse E., van-der-Linden P.D., Leufkens H.G. et al. Asthma medications and disease exacerbations: an epidemiological study as a method for asthma surveillance//Eur. Respir. J. -1995 Nov. -Vol. 8. -№ 11. -P. 1856−1860.
- Van-Grunsven P.M., Van-Schayck C.P., Molema J. et al. Effect of inhaled corticosteroids on bronchial responsiveness in patients with «corticosteroid naive» mild asthma: a meta-analysis//Thorax. -1999 Apt. -Vol. 54. -№ 4. -P. 316−322.
- Van-Hal P.T., Overbeek S.E., Hoogstenden H.C. et al. Eicosanoids and lipocortin-1 in BAL fluid in asthma- effects of smoking and inhaled glucocorticoids//! Appl. Physiol. -1996 Aug. -Vol. 81. -№ 2. -P. 548−555.
- Vatheneh A.S., Knox A.J., Wisniewski A et al. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma//Ibid. -1991. -Vol. 143. -P. 1317−1321.
- Vav-renses E.L., Straathof K.C., Veselic-Charvat M.F. et al. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils and exhaled nitric oxide levels in patients with asthma//Thorax. -1999 May. -Vol. 54. -№ 50. -P. 403−408.
- Verberne A.A., Frost C., Roorda R.J. et al. One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group//Am. J. Respir. Crit. Care Med. -1997 Sep. -Vol. 156. -№ 3 (Ptl). -P. 688−695.
- Verheggen M.M., Adriaansen-Soeting P.W., Berrevoets C.A. et al. Glucocorticoid receptor expression in human bronchial epithelial cells: effects of smoking and COPD//Mediators-Inflamm. -1998. -Vol. 7. -№ 4. -P. 275−281.
- Viksman M.Y., Liu M.C., Bickel C.A. et al. Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation//Am. J. Respir. Crit. Care Med. -1997. -Vol. 155. -P. 858−863.
- Vrugt В., Djukanovic R., Bron R. et al. New insights into the pathogenesis of severe corticosteroid-dependent asthma//! Allergy Clin. Immunol. -1996 Nov. -Vol. 98. -№ 5 (Pt2). -P. 22−26.
- Vrugt В., Wilson S., Underwood J. et al. Mucosal inflammation in severe glucocorticoid-dependent asthma//Eur. Respir. J. -1999 Jun. -Vol. 13. -№ 6. -P. 1245−1252.
- Walker С., Kaegi M.K., Braiin P. et al. Activated T-cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity//! Allergy Clin. Immunol. -1991. -Vol. 88. -P. 935−942.
- Ward J.K., Belvisi M.G., Fox A.J. et al. Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro//J. Clin. Invest. -1993. -Vol. 92. -P. 736−743.
- Wardlaw A.J., Dunette S., Gleich G.J. et al. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma//Am. Rev. Respir. Dis. -1988. -Vol. 137. -P. 62−69.
- Wardlaw A.J., Dunnette S., Gleich G.J. et al. Eosinophils and mast cells in bronchoalveolar lavage in subjects with asthma and subjects with chronic airflow inflammation//Am. Rev. Respir. Dis. -1992. -Vol. 145. -P. 922−927.
- Warner J.O. Asthma: A follow up statement from an international paediatric asthma consensus group//Arch. Dis. Child. -1992. -Vol. 67. -P. 240−248.
- Watanabe K., Senju S., Toyoshima H. et al. Thickness of the basement membrane of bronchial epithelial cells in lung diseases as determined by transbronchial biopsy/ZRespir. Med. -1997 Aug. -Vol. 91. -№ 7. -P. 406−410.
- Watkins N., Knight D., Garlepp M. et al. Inducible nitric oxide synthase mRNA in human airway epithelium//Eur. Resp. J. -1995. .-Vol. 8. -S. 19. -P. 41.
- Welch M.J. Inhaled steroids and severe viral infections//J. Asthma. -1994. -Vol. 31.-P. 43−50.
- Wennergren G., Nordvall S.L., Hedlin G. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers//Acta-Paediatr. -1996 Feb. -Vol. 85. -№ 2. -P. 183−189.
- Wenzel S.E., Szefler S.J., Leung D.Y. et al. Bronchoscope evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids//Am. J. Respir. Crit. Care Med. -1997 Sep. -Vol. 156. -№ 3 (Ptl). -P. 737−743.
- Wever A.M., Wever-Hess J., Hermans J. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma//Clin. Exp. Allergy. -1997 May. -Vol. 27. -№ 5. -P. 519−529.
- Wilson J.W., Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway//Clin. Exp. Allergy. -1997 Apr. -Vol. 27. -№ 4. -P. 363−371.
- Wilson N.M., Silverman M. Treatment of acute, episodic asthma in pre-school children using intermittent high dose inhaled steroids at home//Arch. Dis. Child. -1990. -Vol. 65. -P. 407−410.
- Wisniewski A., Lewis S., Maslanka W.B. et al. A cross-sectional study of the effects of inhaled steroids on bone density & bone metabolism in patients with asthma//Am. J. Respir. Crit. Care Med. -1995. -Vol. 151. -P. 374.
- Wolthers O.D. Long, -intermediate, -and short-term growth studies in asthmatic children treated with inhaled glucocorticosteroids//Eur. Respir. J. -1996. -Vol. 9. -№ 4. -P. 821−827.
- Wolthers O.D., Juul A., Hansen M. et al. The insulin-like growth factor axis and collagen turnover in asthmatic children treated with inhaled budesonide//Acta Paediatr. -1995. -Vol. 84. -P. 393−397.
- Wolthers O.D., Heuck C. Differential effects of inhaled budesonide on serum osteocalcin in children and adolescents with asthma/ZPediatr. Allergy Immunol. -1998 Aug. -Vol. 9. -№ 3. -P. 150−155.
- Wolthers O.D., Pedersen S. Growth of asthmatic children during treatment with budesonide: A double blind trial//Ibid. -1991. -Vol. 303. -№ 6795. -P. 163−165.
- Wolthers O.D., Pedersen S. Linear growth in asthmatic schoolchildren treated with inhaled budesonide//Eur. Respir. J. -1992. -Vol. 5. -Suppl. 5. -P. 1004−1006.
- Woolley K.I., Adelroth E., Woolley M.J. et al. Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophils cationic protein in subjects with and without mild, stable, atopic asthma//Eur. Respir. J. -1994. -Vol. 7. -P. 1576−1584.
- Wurthwein G, Rohdewald P. Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate//Biopharm. Drug Dispos. -1990. -Vol. 11.-P. 381−394.
- Xiang X., Zhou H., Yao W. Effects of inhalated isosorbide dinitrate on endothelin and nitric oxide and its therapeutic efficacy for experimental guinea-pigs with asthma/ZHunan I Ко Та Hsueh Hsueh Pao. -1997. -Vol. 22. -№ 3. -P. 220−222.
- Yates D.H., Kharitonov S.A., Robbins R.A. et al. Effect of a nitric oxide synthase inhibitor and glucocortocosteroids on exhaled nitric oxideZZAm. J. Respir. Crit. Care Med. -1995. -Vol. 152. -P. 892−896.
- Yavuz O., Turktas I., Cevik C. The effect of high-dose inhaled budesonide on lipid profile ib asthmatic patientsZZGen. Pharmacol. -1996 Jan. -Vol. 27. -№ 1. -P. 89−90.
- Yokoyama A., Kohno N., Hamada H. et al. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis//Am. J. Respir. Crit. Care Med. -1998 Nov. -Vol. 158. -№ 5 (Ptl). -P. 1680−1684.
- Yokoyama A., Kohno N., Kondo K. et al. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19−9 and SLX as serum markers for interstitial pneumonia/ZRespirology. -1998 Sep. -Vol. 3. -№ 3. -P. 199−202.
- Yu G., Bjorksten B. Polyunsaturated fatty acids in school children in relation to allergy and serum IgE levels/ZPediatr. Allergy Immunol. -1998 Aug. -Vol. 9. -№ 3. -P. 133 138.
- Zaitsu M., Hamasaki Y., Ishii K. et al. Direct evidence that LTC4 and LTB4 but not TXA2 are involved in asthma attacks in children//! Asthma. -1998. -Vol. 35. -№ 5. -P. 445−448.
- Zhang H., Yang Y., Weng X. A preliminary observation on the effects of inhaled nitric oxide on bronchial asthma//Chung Hua Nei Ко Tsa Chih. -1995 Dec. -Vol. 34. -№ 12. -P. 805−807.
- ZuWallack R.L., Rosen J.P., Cohen L. et al. The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control//! Allergy Clin. Immunol. -1997 Mar. -Vol. 99. -№ 3. -P. 278−285.О